_id,PNO,Content,FilePath
JB343810,EP2543365A1,"ID   JB343810; SV 1; linear; other DNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB343810;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 8 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/8, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; f2bd3702166d42499e9cce57454de7d2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 7 C; 4 G; 4 T; 0 other;\r\n     cagagcactt gatcgcctac aa                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343809,EP2543365A1,"ID   JB343809; SV 1; linear; other DNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB343809;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 7 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/7, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; 7d11f468041ffd5ac3f09efed8396791.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 7 A; 7 C; 4 G; 3 T; 0 other;\r\n     ccacagcaag tcacacattg g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343808,EP2543365A1,"ID   JB343808; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB343808;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 6 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/6, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; 6b8d2a153b0469623ecae279eafde20b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 7 C; 4 G; 6 T; 0 other;\r\n     accttcccca tggtgtctga                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343807,EP2543365A1,"ID   JB343807; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB343807;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 5 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/5, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; 9e5375f915f0ea7ac7a73bee666b2133.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 8 C; 3 G; 6 T; 0 other;\r\n     ctcctcctgt tcgacagtca                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343806,EP2543365A1,"ID   JB343806; SV 1; linear; other DNA; PAT; SYN; 56 BP.\r\nXX\r\nAC   JB343806;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 4 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/4, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; 8a8f2aacafa57890dde7c19f952b881d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..56\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 56 BP; 21 A; 8 C; 9 G; 18 T; 0 other;\r\n     tgcagaaaaa gttaatggct acgaattatt ctcttgaaat aattcgtagc cattaa            56\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343805,EP2543365A1,"ID   JB343805; SV 1; linear; other DNA; PAT; SYN; 56 BP.\r\nXX\r\nAC   JB343805;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 3 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/3, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; c03838bc780ea4360f8dde41d3568e8b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..56\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 56 BP; 18 A; 10 C; 8 G; 20 T; 0 other;\r\n     accgttaatg gctacgaatt atttcaagag aataattcgt agccattaac tttttc            56\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343804,EP2543365A1,"ID   JB343804; SV 1; linear; other DNA; PAT; SYN; 56 BP.\r\nXX\r\nAC   JB343804;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 2 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/2, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; b6415768f91ac84264983405dce3b081.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..56\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 56 BP; 21 A; 8 C; 9 G; 18 T; 0 other;\r\n     tgcagaaaaa gggataccgt ttaatttaat ctcttgaatt aaattaaacg gtatcc            56\r\n//\r\n",rel_pat_syn_07_r122.dat
JB343803,EP2543365A1,"ID   JB343803; SV 1; linear; other DNA; PAT; SYN; 56 BP.\r\nXX\r\nAC   JB343803;\r\nXX\r\nDT   26-SEP-2013 (Rel. 118, Created)\r\nDT   26-SEP-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 1 from Patent EP2543365.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   DE B.O., SCHUSTER T.B., SHANKER V., MEIER W.P.;\r\nRT   ""Peptide beads"";\r\nRL   Patent number EP2543365-A1/1, 09-JAN-2013.\r\nRL   UNIV BASEL [CH].\r\nXX\r\nDR   MD5; e781906fc73adb91db7c118d22ded7c1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..56\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Synthetic construct' /mol_type='other DNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 56 BP; 18 A; 10 C; 8 G; 20 T; 0 other;\r\n     accgggatac cgtttaattt aattcaagag attaaattaa acggtatccc tttttc            56\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420465,EP2589606A1,"ID   JB420465; SV 1; linear; other DNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB420465;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 28 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/28, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 5ec1d20b40f8f8c9ed7341a77d82054f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H3 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 5 C; 4 G; 9 T; 0 other;\r\n     ctaagtttct atgctatgga ctac                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420464,EP2589606A1,"ID   JB420464; SV 1; linear; other DNA; PAT; SYN; 51 BP.\r\nXX\r\nAC   JB420464;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 27 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/27, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 434e92059ed09147817a8512a8358bcb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..51\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H2 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 51 BP; 15 A; 9 C; 13 G; 14 T; 0 other;\r\n     tacattagta atggtggtgg tagcacctat tatccagaca ctgtaaaggg c                 51\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420463,EP2589606A1,"ID   JB420463; SV 1; linear; other DNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB420463;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 26 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/26, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 2df311cdc2d11e356cb8dcdd41917e85.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H1 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 6 A; 2 C; 3 G; 7 T; 0 other;\r\n     agtgactatt acatgtat                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420462,EP2589606A1,"ID   JB420462; SV 1; linear; other DNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JB420462;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 25 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/25, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; ad597eaa688913f49e7771eb22c5763a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light Chain CDR-L3 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 9 A; 7 C; 4 G; 7 T; 0 other;\r\n     cagcaacatt ataggattcc attcacg                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420461,EP2589606A1,"ID   JB420461; SV 1; linear; other DNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB420461;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 24 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/24, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 8459b57ded70b283293011b593907876.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light Chain CDR-L2 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 9 C; 5 G; 3 T; 0 other;\r\n     tgggcatcca cccggcacac t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420460,EP2589606A1,"ID   JB420460; SV 1; linear; other DNA; PAT; SYN; 33 BP.\r\nXX\r\nAC   JB420460;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 23 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/23, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 24f88d589f8a2ab1c1c3db31ff63f370.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..33\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light Chain CDR-L1 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 33 BP; 8 A; 8 C; 10 G; 7 T; 0 other;\r\n     aaggccagtc aggatgtgac tactgctgta gcc                                     33\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420459,EP2589606A1,"ID   JB420459; SV 1; linear; other DNA; PAT; SYN; 351 BP.\r\nXX\r\nAC   JB420459;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 22 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/22, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 148ec5097e8314b52fd9fd53025a727f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..351\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy chain variable domain""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 351 BP; 89 A; 82 C; 95 G; 85 T; 0 other;\r\n     gaagtgaagc tggtggagtc tgggggaggc ttagtgcagc ctggagggtc cctgaaactc        60\r\n     tcctgtgcaa cctctggatt cactttcagt gactattaca tgtattgggt tcgccagact       120\r\n     ccagagaaga ggctggagtg ggtcgcatac attagtaatg gtggtggtag cacctattat       180\r\n     ccagacactg taaagggccg attcaccatg tccagagaca atgccaagaa caccctgtac       240\r\n     ctgcaaatga gccgtctgaa gtctgaggac acagccatgt attactgtgc aagactaagt       300\r\n     ttctatgcta tggactactg gggtcaagga acctcagtca ccgtctcctc a                351\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420458,EP2589606A1,"ID   JB420458; SV 1; linear; other DNA; PAT; SYN; 321 BP.\r\nXX\r\nAC   JB420458;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 21 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/21, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 927c455283fb2553c1dedb187fbc6b1d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..321\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light chain variable domain""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 321 BP; 92 A; 82 C; 73 G; 74 T; 0 other;\r\n     gacattgtga tgacccagtc tcacaaattc atgtccacat cagtaggaga cagggtcagc        60\r\n     atcacctgca aggccagtca ggatgtgact actgctgtag cctggtatca acaaaaacca       120\r\n     ggacaatctc ctaaactact gatttactgg gcatccaccc ggcacactgg agtccctgat       180\r\n     cgcttcacag gcagtggatc tgggacagat tatactctca ccatcagcag tgtgcaggct       240\r\n     gaagacctgg cactttatta ctgtcagcaa cattatagga ttccattcac gttcggctcg       300\r\n     gggacaaagt tggaaataaa a                                                 321\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420457,EP2589606A1,"ID   JB420457; SV 1; linear; other DNA; PAT; SYN; 30 BP.\r\nXX\r\nAC   JB420457;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 20 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/20, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; d33814f59f141d8c05bc15c7c9ec0fc7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..30\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H3 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 30 BP; 9 A; 6 C; 6 G; 9 T; 0 other;\r\n     gcaagactaa gtttctatgc tatggactac                                         30\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420456,EP2589606A1,"ID   JB420456; SV 1; linear; other DNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB420456;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 19 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/19, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 47c72b26ee13aaac1621fc0b7382f10f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H2 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 3 C; 8 G; 7 T; 0 other;\r\n     attagtaatg gtggtggtag cacc                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420455,EP2589606A1,"ID   JB420455; SV 1; linear; other DNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB420455;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 18 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/18, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; aca5da81fb93e00ede17fc73049f277e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Heavy Chain CDR-H1 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 5 C; 4 G; 9 T; 0 other;\r\n     ggattcactt tcagtgacta ttac                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420454,EP2589606A1,"ID   JB420454; SV 1; linear; other DNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JB420454;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 17 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/17, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; ad597eaa688913f49e7771eb22c5763a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light Chain CDR-L3 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 9 A; 7 C; 4 G; 7 T; 0 other;\r\n     cagcaacatt ataggattcc attcacg                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420453,EP2589606A1,"ID   JB420453; SV 1; linear; other DNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB420453;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 15 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/15, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; bf1d17d9428c03151c28e7a04507ee9d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Light Chain CDR-L1 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 4 C; 5 G; 5 T; 0 other;\r\n     caggatgtga ctactgct                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB420472,EP2589606A1,"ID   JB420472; SV 1; linear; protein; PRT; SYN; 5 AA.\r\nXX\r\nAC   JB420472;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 35 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/35, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 7407cb1136c61996ad7143725f31f92e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..5\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Pentapeptide""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 5 AA; 470 MW; F4940201 CRC32;\r\n     PVGVV                                                                     5\r\n//\r\n",epo_prt.dat
JB420471,EP2589606A1,"ID   JB420471; SV 1; linear; protein; PRT; SYN; 4 AA.\r\nXX\r\nAC   JB420471;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 34 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/34, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 3f4f0645dc7859e47a25a5659f33bc38.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..4\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Tetrapeptide""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 4 AA; 386 MW; 129B18E0 CRC32;\r\n     ALAL                                                                      4\r\n//\r\n",epo_prt.dat
JB420470,EP2589606A1,"ID   JB420470; SV 1; linear; protein; PRT; SYN; 4 AA.\r\nXX\r\nAC   JB420470;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 33 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/33, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; fbcf64501111d0eaf0b4d26c767b38ea.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..4\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Tetrapeptide""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 4 AA; 392 MW; 181B652F CRC32;\r\n     GFLG                                                                      4\r\n//\r\n",epo_prt.dat
JB420469,EP2589606A1,"ID   JB420469; SV 1; linear; protein; PRT; HUM; 426 AA.\r\nXX\r\nAC   JB420469;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 32 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/32, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; fc422b45d96af0d712a6c02df15d4191.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..426\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""protein""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 426 AA; 46152 MW; BD646EE CRC32;\r\n     APRGTQAEES PFVGNPGNIT GARGLTGTLR CQLQVQGEPP EVHWLRDGQI LELADSTQTQ        60\r\n     VPLGEDEQDD WIVVSQLRIT SLQLSDTGQY QCLVFLGHQT FVSQPGYVGL EGLPYFLEEP       120\r\n     EDRTVAANTP FNLSCQAQGP PEPVDLLWLQ DAVPLATAPG HGPQRSLHVP GLNKTSSFSC       180\r\n     EAHNAKGVTT SRTATITVLP QQPRNLHLVS RQPTELEVAW TPGLSGIYPL THCTLQAVLS       240\r\n     NDGMGIQAGE PDPPEEPLTS QASVPPHQLR LGSLHPHTPY HIRVACTSSQ GPSSWTHWLP       300\r\n     VETPEGVPLG PPENISATRN GSQAFVHWQE PRAPLQGTLL GYRLAYQGQD TPEVLMDIGL       360\r\n     RQEVTLELQG DGSVSNLTVC VAAYTAAGDG PWSLPVPLEA WRPGQAQPVH QLVKEPSTPA       420\r\n     FSWPWW                                                                  426\r\n//\r\n",epo_prt.dat
JB420468,EP2589606A1,"ID   JB420468; SV 1; linear; protein; PRT; HUM; 451 AA.\r\nXX\r\nAC   JB420468;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 31 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/31, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 37aa9459101fb75c95cd05bdb2ef9907.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..451\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""protein""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 451 AA; 49017 MW; BA7F6EE3 CRC32;\r\n     MAWRCPRMGR VPLAWCLALC GWACMAPRGT QAEESPFVGN PGNITGARGL TGTLRCQLQV        60\r\n     QGEPPEVHWL RDGQILELAD STQTQVPLGE DEQDDWIVVS QLRITSLQLS DTGQYQCLVF       120\r\n     LGHQTFVSQP GYVGLEGLPY FLEEPEDRTV AANTPFNLSC QAQGPPEPVD LLWLQDAVPL       180\r\n     ATAPGHGPQR SLHVPGLNKT SSFSCEAHNA KGVTTSRTAT ITVLPQQPRN LHLVSRQPTE       240\r\n     LEVAWTPGLS GIYPLTHCTL QAVLSNDGMG IQAGEPDPPE EPLTSQASVP PHQLRLGSLH       300\r\n     PHTPYHIRVA CTSSQGPSSW THWLPVETPE GVPLGPPENI SATRNGSQAF VHWQEPRAPL       360\r\n     QGTLLGYRLA YQGQDTPEVL MDIGLRQEVT LELQGDGSVS NLTVCVAAYT AAGDGPWSLP       420\r\n     VPLEAWRPGQ AQPVHQLVKE PSTPAFSWPW W                                      451\r\n//\r\n",epo_prt.dat
JB420467,EP2589606A1,"ID   JB420467; SV 1; linear; protein; PRT; HUM; 869 AA.\r\nXX\r\nAC   JB420467;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 30 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/30, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 7c8b91af1e24d842a4761c98ef1243a1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..869\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""protein""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 869 AA; 95470 MW; CBBC7A21 CRC32;\r\n     APRGTQAEES PFVGNPGNIT GARGLTGTLR CQLQVQGEPP EVHWLRDGQI LELADSTQTQ        60\r\n     VPLGEDEQDD WIVVSQLRIT SLQLSDTGQY QCLVFLGHQT FVSQPGYVGL EGLPYFLEEP       120\r\n     EDRTVAANTP FNLSCQAQGP PEPVDLLWLQ DAVPLATAPG HGPQRSLHVP GLNKTSSFSC       180\r\n     EAHNAKGVTT SRTATITVLP QQPRNLHLVS RQPTELEVAW TPGLSGIYPL THCTLQAVLS       240\r\n     NDGMGIQAGE PDPPEEPLTS QASVPPHQLR LGSLHPHTPY HIRVACTSSQ GPSSWTHWLP       300\r\n     VETPEGVPLG PPENISATRN GSQAFVHWQE PRAPLQGTLL GYRLAYQGQD TPEVLMDIGL       360\r\n     RQEVTLELQG DGSVSNLTVC VAAYTAAGDG PWSLPVPLEA WRPGQAQPVH QLVKEPSTPA       420\r\n     FSWPWWYVLL GAVVAAACVL ILALFLVHRR KKETRYGEVF EPTVERGELV VRYRVRKSYS       480\r\n     RRTTEATLNS LGISEELKEK LRDVMVDRHK VALGKTLGEG EFGAVMEGQL NQDDSILKVA       540\r\n     VKTMKIAICT RSELEDFLSE AVCMKEFDHP NVMRLIGVCF QGSERESFPA PVVILPFMKH       600\r\n     GDLHSFLLYS RLGDQPVYLP TQMLVKFMAD IASGMEYLST KRFIHRDLAA RNCMLNENMS       660\r\n     VCVADFGLSK KIYNGDYYRQ GRIAKMPVKW IAIESLADRV YTSKSDVWSF GVTMWEIATR       720\r\n     GQTPYPGVEN SEIYDYLRQG NRLKQPADCL DGLYALMSRC WELNPQDRPS FTELREDLEN       780\r\n     TLKALPPAQE PDEILYVNMD EGGGYPEPPG AAGGADPPTQ PDPKDSCSCL TAAEVHPAGR       840\r\n     YVLCPSTTPS PAQPADRGSP AAPGQEDGA                                         869\r\n//\r\n",epo_prt.dat
JB420466,EP2589606A1,"ID   JB420466; SV 1; linear; protein; PRT; HUM; 894 AA.\r\nXX\r\nAC   JB420466;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 29 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/29, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 362e54774b909b6b783ca54be8166e47.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..894\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""protein""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 894 AA; 98335 MW; 652148D9 CRC32;\r\n     MAWRCPRMGR VPLAWCLALC GWACMAPRGT QAEESPFVGN PGNITGARGL TGTLRCQLQV        60\r\n     QGEPPEVHWL RDGQILELAD STQTQVPLGE DEQDDWIVVS QLRITSLQLS DTGQYQCLVF       120\r\n     LGHQTFVSQP GYVGLEGLPY FLEEPEDRTV AANTPFNLSC QAQGPPEPVD LLWLQDAVPL       180\r\n     ATAPGHGPQR SLHVPGLNKT SSFSCEAHNA KGVTTSRTAT ITVLPQQPRN LHLVSRQPTE       240\r\n     LEVAWTPGLS GIYPLTHCTL QAVLSNDGMG IQAGEPDPPE EPLTSQASVP PHQLRLGSLH       300\r\n     PHTPYHIRVA CTSSQGPSSW THWLPVETPE GVPLGPPENI SATRNGSQAF VHWQEPRAPL       360\r\n     QGTLLGYRLA YQGQDTPEVL MDIGLRQEVT LELQGDGSVS NLTVCVAAYT AAGDGPWSLP       420\r\n     VPLEAWRPGQ AQPVHQLVKE PSTPAFSWPW WYVLLGAVVA AACVLILALF LVHRRKKETR       480\r\n     YGEVFEPTVE RGELVVRYRV RKSYSRRTTE ATLNSLGISE ELKEKLRDVM VDRHKVALGK       540\r\n     TLGEGEFGAV MEGQLNQDDS ILKVAVKTMK IAICTRSELE DFLSEAVCMK EFDHPNVMRL       600\r\n     IGVCFQGSER ESFPAPVVIL PFMKHGDLHS FLLYSRLGDQ PVYLPTQMLV KFMADIASGM       660\r\n     EYLSTKRFIH RDLAARNCML NENMSVCVAD FGLSKKIYNG DYYRQGRIAK MPVKWIAIES       720\r\n     LADRVYTSKS DVWSFGVTMW EIATRGQTPY PGVENSEIYD YLRQGNRLKQ PADCLDGLYA       780\r\n     LMSRCWELNP QDRPSFTELR EDLENTLKAL PPAQEPDEIL YVNMDEGGGY PEPPGAAGGA       840\r\n     DPPTQPDPKD SCSCLTAAEV HPAGRYVLCP STTPSPAQPA DRGSPAAPGQ EDGA             894\r\n//\r\n",epo_prt.dat
JB420452,EP2589606A1,"ID   JB420452; SV 1; linear; protein; PRT; SYN; 8 AA.\r\nXX\r\nAC   JB420452;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 14 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/14, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 562f1c9c6c1f3f961c89ecb373748051.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..8\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H3 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 8 AA; 1009 MW; C798024F CRC32;\r\n     LSFYAMDY                                                                  8\r\n//\r\n",epo_prt.dat
JB420451,EP2589606A1,"ID   JB420451; SV 1; linear; protein; PRT; SYN; 17 AA.\r\nXX\r\nAC   JB420451;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 13 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/13, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 76743c33dfcdc813c33a108058a67db1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..17\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H2 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 17 AA; 1779 MW; 772B7024 CRC32;\r\n     YISNGGGSTY YPDTVKG                                                       17\r\n//\r\n",epo_prt.dat
JB420450,EP2589606A1,"ID   JB420450; SV 1; linear; protein; PRT; SYN; 6 AA.\r\nXX\r\nAC   JB420450;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 12 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/12, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 2e0e77d313cc99c81fccb551595e5599.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..6\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H1 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 6 AA; 841 MW; EB5C5783 CRC32;\r\n     SDYYMY                                                                    6\r\n//\r\n",epo_prt.dat
JB420449,EP2589606A1,"ID   JB420449; SV 1; linear; protein; PRT; SYN; 9 AA.\r\nXX\r\nAC   JB420449;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 11 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/11, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; f419a30fead5c45e43445073ba1beae6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..9\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light Chain CDR-L3 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 9 AA; 1189 MW; BB60F7DF CRC32;\r\n     QQHYRIPFT                                                                 9\r\n//\r\n",epo_prt.dat
JB420448,EP2589606A1,"ID   JB420448; SV 1; linear; protein; PRT; SYN; 7 AA.\r\nXX\r\nAC   JB420448;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 10 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/10, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; b3be10af5d725c5dbfd6d758edc1377f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light Chain CDR-L2 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 AA; 858 MW; 40A7A9A1 CRC32;\r\n     WASTRHT                                                                   7\r\n//\r\n",epo_prt.dat
JB420447,EP2589606A1,"ID   JB420447; SV 1; linear; protein; PRT; SYN; 11 AA.\r\nXX\r\nAC   JB420447;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 9 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/9, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 7b69a16a781113af4f495603c380c322.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..11\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light Chain CDR-L1 from 110D7 antibody (Kabat\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 11 AA; 1090 MW; BD371590 CRC32;\r\n     KASQDVTTAV A                                                             11\r\n//\r\n",epo_prt.dat
JB420446,EP2589606A1,"ID   JB420446; SV 1; linear; protein; PRT; SYN; 117 AA.\r\nXX\r\nAC   JB420446;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 8 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/8, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 635a75d77a315ff5b5c8d37eefdca926.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..117\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy chain variable domain""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 117 AA; 13162 MW; A0883B6C CRC32;\r\n     EVKLVESGGG LVQPGGSLKL SCATSGFTFS DYYMYWVRQT PEKRLEWVAY ISNGGGSTYY        60\r\n     PDTVKGRFTM SRDNAKNTLY LQMSRLKSED TAMYYCARLS FYAMDYWGQG TSVTVSS          117\r\n//\r\n",epo_prt.dat
JB420445,EP2589606A1,"ID   JB420445; SV 1; linear; protein; PRT; SYN; 107 AA.\r\nXX\r\nAC   JB420445;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 7 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/7, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; d9fe3af99f7bfd6d2eb2f2027e92766d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..107\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light chain variable domain""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 107 AA; 11888 MW; 3DE218C CRC32;\r\n     DIVMTQSHKF MSTSVGDRVS ITCKASQDVT TAVAWYQQKP GQSPKLLIYW ASTRHTGVPD        60\r\n     RFTGSGSGTD YTLTISSVQA EDLALYYCQQ HYRIPFTFGS GTKLEIK                     107\r\n//\r\n",epo_prt.dat
JB420444,EP2589606A1,"ID   JB420444; SV 1; linear; protein; PRT; SYN; 10 AA.\r\nXX\r\nAC   JB420444;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 6 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/6, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 78f4c9b32b3c59f39ce6722a5a6db1dd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..10\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H3 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 10 AA; 1236 MW; 6CECB03E CRC32;\r\n     ARLSFYAMDY                                                               10\r\n//\r\n",epo_prt.dat
JB420443,EP2589606A1,"ID   JB420443; SV 1; linear; protein; PRT; SYN; 8 AA.\r\nXX\r\nAC   JB420443;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 5 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/5, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; e2008157eca2561dc27860163c59f941.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..8\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H2 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 8 AA; 692 MW; EF358584 CRC32;\r\n     ISNGGGST                                                                  8\r\n//\r\n",epo_prt.dat
JB420442,EP2589606A1,"ID   JB420442; SV 1; linear; protein; PRT; SYN; 8 AA.\r\nXX\r\nAC   JB420442;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 4 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/4, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 00eb26e53d5d18a48edd6e5b5516909f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..8\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Heavy Chain CDR-H1 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 8 AA; 999 MW; 917C634 CRC32;\r\n     GFTFSDYY                                                                  8\r\n//\r\n",epo_prt.dat
JB420441,EP2589606A1,"ID   JB420441; SV 1; linear; protein; PRT; SYN; 9 AA.\r\nXX\r\nAC   JB420441;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 3 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/3, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; f419a30fead5c45e43445073ba1beae6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..9\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light Chain CDR-L3 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 9 AA; 1189 MW; BB60F7DF CRC32;\r\n     QQHYRIPFT                                                                 9\r\n//\r\n",epo_prt.dat
JB420440,EP2589606A1,"ID   JB420440; SV 1; linear; protein; PRT; SYN; 6 AA.\r\nXX\r\nAC   JB420440;\r\nXX\r\nDT   11-OCT-2013 (Rel. 118, Created)\r\nDT   11-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 1 from Patent EP2589606.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BEAU-LARVOR C., GOETSCH L.;\r\nRT   ""Antigen binding protein and its use as addressing product for the\r\nRT   treatment of cancer"";\r\nRL   Patent number EP2589606-A1/1, 08-MAY-2013.\r\nRL   PF MEDICAMENT [FR].\r\nXX\r\nDR   MD5; 3b90138d248165e4dbac9c98c04e8b99.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..6\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""protein""\r\nFT                   /note=""Light Chain CDR-L1 from 110D7 antibody (IMGT\r\nFT                   numbering)""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 6 AA; 634 MW; 7E4344C3 CRC32;\r\n     QDVTTA                                                                    6\r\n//\r\n",epo_prt.dat
JB754055,EP2607483A1,"ID   JB754055; SV 1; linear; unassigned DNA; PAT; HUM; 9385 BP.\r\nXX\r\nAC   JB754055;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 360 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/360, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f8f9027a5524195af9e9a3725dbe66f1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..9385\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""unassigned DNA""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 9385 BP; 3030 A; 1685 C; 1973 G; 2697 T; 0 other;\r\n     gcgagaggag tcgggatctg cgctgcagcc accgccgcgg ttgatactac tttgaccttc        60\r\n     cgagtgcagt gaggcataca tcacaatttg gaattatgca ttggtttatc aatttacttg       120\r\n     tttattgtca ccctgctgcc cagatatgac ttcatgagga cagtgatgtg tgttctgaaa       180\r\n     ttgtgaacca tgagtctagt acttaatgat ctgcttatct gctgccgtca actagaacat       240\r\n     gatagagcta cagaacgaaa gaaagaagtt gagaaattta agcgcctgat tcgagatcct       300\r\n     gaaacaatta aacatctaga tcggcattca gattccaaac aaggaaaata tttgaattgg       360\r\n     gatgctgttt ttagattttt acagaaatat attcagaaag aaacagaatg tctgagaata       420\r\n     gcaaaaccaa atgtatcagc ctcaacacaa gcctccaggc agaaaaagat gcaggaaatc       480\r\n     agtagtttgg tcaaatactt catcaaatgt gcaaacagaa gagcacctag gctaaaatgt       540\r\n     caagaactct taaattatat catggataca gtgaaagatt catctaatgg tgctatttac       600\r\n     ggagctgatt gtagcaacat actactcaaa gacattcttt ctgtgagaaa atactggtgt       660\r\n     gaaatatctc agcaacagtg gttagaattg ttctctgtgt acttcaggct ctatctgaaa       720\r\n     ccttcacaag atgttcatag agttttagtg gctagaataa ttcatgctgt taccaaagga       780\r\n     tgctgttctc agactgacgg attaaattcc aaatttttgg actttttttc caaggctatt       840\r\n     cagtgtgcga gacaagaaaa gagctcttca ggtctaaatc atatcttagc agctcttact       900\r\n     atcttcctca agactttggc tgtcaacttt cgaattcgag tgtgtgaatt aggagatgaa       960\r\n     attcttccca ctttgcttta tatttggact caacataggc ttaatgattc tttaaaagaa      1020\r\n     gtcattattg aattatttca actgcaaatt tatatccatc atccgaaagg agccaaaacc      1080\r\n     caagaaaaag gtgcttatga atcaacaaaa tggagaagta ttttatacaa cttatatgat      1140\r\n     ctgctagtga atgagataag tcatatagga agtagaggaa agtattcttc aggatttcgt      1200\r\n     aatattgccg tcaaagaaaa tttgattgaa ttgatggcag atatctgtca ccaggttttt      1260\r\n     aatgaagata ccagatcctt ggagatttct caatcttaca ctactacaca aagagaatct      1320\r\n     agtgattaca gtgtcccttg caaaaggaag aaaatagaac taggctggga agtaataaaa      1380\r\n     gatcaccttc agaagtcaca gaatgatttt gatcttgtgc cttggctaca gattgcaacc      1440\r\n     caattaatat caaagtatcc tgcaagttta cctaactgtg agctgtctcc attactgatg      1500\r\n     atactatctc agcttctacc ccaacagcga catggggaac gtacaccata tgtgttacga      1560\r\n     tgccttacgg aagttgcatt gtgtcaagac aagaggtcaa acctagaaag ctcacaaaag      1620\r\n     tcagatttat taaaactctg gaataaaatt tggtgtatta cctttcgtgg tataagttct      1680\r\n     gagcaaatac aagctgaaaa ctttggctta cttggagcca taattcaggg tagtttagtt      1740\r\n     gaggttgaca gagaattctg gaagttattt actgggtcag cctgcagacc ttcatgtcct      1800\r\n     gcagtatgct gtttgacttt ggcactgacc accagtatag ttccaggagc ggtaaaaatg      1860\r\n     ggaatagagc aaaatatgtg tgaagtaaat agaagctttt ctttaaagga atcaataatg      1920\r\n     aaatggctct tattctatca gttagagggt gacttagaaa atagcacaga agtgcctcca      1980\r\n     attcttcaca gtaattttcc tcatcttgta ctggagaaaa ttcttgtgag tctcactatg      2040\r\n     aaaaactgta aagctgcaat gaattttttc caaagcgtgc cagaatgtga acaccaccaa      2100\r\n     aaagataaag aagaactttc attctcagaa gtagaagaac tatttcttca gacaactttt      2160\r\n     gacaagatgg actttttaac cattgtgaga gaatgtggta tagaaaagca ccagtccagt      2220\r\n     attggcttct ctgtccacca gaatctcaag gaatcactgg atcgctgtct tctgggatta      2280\r\n     tcagaacagc ttctgaataa ttactcatct gagattacaa attcagaaac tcttgtccgg      2340\r\n     tgttcacgtc ttttggtggg tgtccttggc tgctactgtt acatgggtgt aatagctgaa      2400\r\n     gaggaagcat ataagtcaga attattccag aaagccaact ctctaatgca atgtgcagga      2460\r\n     gaaagtatca ctctgtttaa aaataagaca aatgaggaat tcagaattgg ttccttgaga      2520\r\n     aatatgatgc agctatgtac acgttgcttg agcaactgta ccaagaagag tccaaataag      2580\r\n     attgcatctg gctttttcct gcgattgtta acatcaaagc taatgaatga cattgcagat      2640\r\n     atttgtaaaa gtttagcatc cttcatcaaa aagccatttg accgtggaga agtagaatca      2700\r\n     atggaagatg atactaatgg aaatctaatg gaggtggagg atcagtcatc catgaatcta      2760\r\n     tttaacgatt accctgatag tagtgttagt gatgcaaacg aacctggaga gagccaaagt      2820\r\n     accataggtg ccattaatcc tttagctgaa gaatatctgt caaagcaaga tctacttttc      2880\r\n     ttagacatgc tcaagttctt gtgtttgtgt gtaactactg ctcagaccaa tactgtgtcc      2940\r\n     tttagggcag ctgatattcg gaggaaattg ttaatgttaa ttgattctag cacgctagaa      3000\r\n     cctaccaaat ccctccacct gcatatgtat ctaatgcttt taaaggagct tcctggagaa      3060\r\n     gagtacccct tgccaatgga agatgttctt gaacttctga aaccactatc caatgtgtgt      3120\r\n     tctttgtatc gtcgtgacca agatgtttgt aaaactattt taaaccatgt ccttcatgta      3180\r\n     gtgaaaaacc taggtcaaag caatatggac tctgagaaca caagggatgc tcaaggacag      3240\r\n     tttcttacag taattggagc attttggcat ctaacaaagg agaggaaata tatattctct      3300\r\n     gtaagaatgg ccctagtaaa ttgccttaaa actttgcttg aggctgatcc ttattcaaaa      3360\r\n     tgggccattc ttaatgtaat gggaaaagac tttcctgtaa atgaagtatt tacacaattt      3420\r\n     cttgctgaca atcatcacca agttcgcatg ttggctgcag agtcaatcaa tagattgttc      3480\r\n     caggacacga agggagattc ttccaggtta ctgaaagcac ttcctttgaa gcttcagcaa      3540\r\n     acagcttttg aaaatgcata cttgaaagct caggaaggaa tgagagaaat gtcccatagt      3600\r\n     gctgagaacc ctgaaacttt ggatgaaatt tataatagaa aatctgtttt actgacgttg      3660\r\n     atagctgtgg ttttatcctg tagccctatc tgcgaaaaac aggctttgtt tgccctgtgt      3720\r\n     aaatctgtga aagagaatgg attagaacct caccttgtga aaaaggtttt agagaaagtt      3780\r\n     tctgaaactt ttggatatag acgtttagaa gactttatgg catctcattt agattatctg      3840\r\n     gttttggaat ggctaaatct tcaagatact gaatacaact tatcttcttt tccttttatt      3900\r\n     ttattaaact acacaaatat tgaggatttc tatagatctt gttataaggt tttgattcca      3960\r\n     catctggtga ttagaagtca ttttgatgag gtgaagtcca ttgctaatca gattcaagag      4020\r\n     gactggaaaa gtcttctaac agactgcttt ccaaagattc ttgtaaatat tcttccttat      4080\r\n     tttgcctatg agggtaccag agacagtggg atggcacagc aaagagagac tgctaccaag      4140\r\n     gtctatgata tgcttaaaag tgaaaactta ttgggaaaac agattgatca cttattcatt      4200\r\n     agtaatttac cagagattgt ggtggagtta ttgatgacgt tacatgagcc agcaaattct      4260\r\n     agtgccagtc agagcactga cctctgtgac ttttcagggg atttggatcc tgctcctaat      4320\r\n     ccacctcatt ttccatcgca tgtgattaaa gcaacatttg cctatatcag caattgtcat      4380\r\n     aaaaccaagt taaaaagcat tttagaaatt ctttccaaaa gccctgattc ctatcagaaa      4440\r\n     attcttcttg ccatatgtga gcaagcagct gaaacaaata atgtttataa gaagcacaga      4500\r\n     attcttaaaa tatatcacct gtttgttagt ttattactga aagatataaa aagtggctta      4560\r\n     ggaggagctt gggcctttgt tcttcgagac gttatttata ctttgattca ctatatcaac      4620\r\n     caaaggcctt cttgtatcat ggatgtgtca ttacgtagct tctccctttg ttgtgactta      4680\r\n     ttaagtcagg tttgccagac agccgtgact tactgtaagg atgctctaga aaaccatctt      4740\r\n     catgttattg ttggtacact tatacccctt gtgtatgagc aggtggaggt tcagaaacag      4800\r\n     gtattggact tgttgaaata cttagtgata gataacaagg ataatgaaaa cctctatatc      4860\r\n     acgattaagc ttttagatcc ttttcctgac catgttgttt ttaaggattt gcgtattact      4920\r\n     cagcaaaaaa tcaaatacag tagaggaccc ttttcactct tggaggaaat taaccatttt      4980\r\n     ctctcagtaa gtgtttatga tgcacttcca ttgacaagac ttgaaggact aaaggatctt      5040\r\n     cgaagacaac tggaactaca taaagatcag atggtggaca ttatgagagc ttctcaggat      5100\r\n     aatccgcaag atgggattat ggtgaaacta gttgtcaatt tgttgcagtt atccaagatg      5160\r\n     gcaataaacc acactggtga aaaagaagtt ctagaggctg ttggaagctg cttgggagaa      5220\r\n     gtgggtccta tagatttctc taccatagct atacaacata gtaaagatgc atcttatacc      5280\r\n     aaggccctta agttatttga agataaagaa cttcagtgga ccttcataat gctgacctac      5340\r\n     ctgaataaca cactggtaga agattgtgtc aaagttcgat cagcagctgt tacctgtttg      5400\r\n     aaaaacattt tagccacaaa gactggacat agtttctggg agatttataa gatgacaaca      5460\r\n     gatccaatgc tggcctatct acagcctttt agaacatcaa gaaaaaagtt tttagaagta      5520\r\n     cccagatttg acaaagaaaa cccttttgaa ggcctggatg atataaatct gtggattcct      5580\r\n     ctaagtgaaa atcatgacat ttggataaag acactgactt gtgctttttt ggacagtgga      5640\r\n     ggcacaaaat gtgaaattct tcaattatta aagccaatgt gtgaagtgaa aactgacttt      5700\r\n     tgtcagactg tacttccata cttgattcat gatattttac tccaagatac aaatgaatca      5760\r\n     tggagaaatc tgctttctac acatgttcag ggatttttca ccagctgtct tcgacacttc      5820\r\n     tcgcaaacga gccgatccac aacccctgca aacttggatt cagagtcaga gcactttttc      5880\r\n     cgatgctgtt tggataaaaa atcacaaaga acaatgcttg ctgttgtgga ctacatgaga      5940\r\n     agacaaaaga gaccttcttc aggaacaatt tttaatgatg ctttctggct ggatttaaat      6000\r\n     tatctagaag ttgccaaggt agctcagtct tgtgctgctc actttacagc tttactctat      6060\r\n     gcagaaatct atgcagataa gaaaagtatg gatgatcaag agaaaagaag tcttgcattt      6120\r\n     gaagaaggaa gccagagtac aactatttct agcttgagtg aaaaaagtaa agaagaaact      6180\r\n     ggaataagtt tacaggatct tctcttagaa atctacagaa gtatagggga gccagatagt      6240\r\n     ttgtatggct gtggtggagg gaagatgtta caacccatta ctagactacg aacatatgaa      6300\r\n     cacgaagcaa tgtggggcaa agccctagta acatatgacc tcgaaacagc aatcccctca      6360\r\n     tcaacacgcc aggcaggaat cattcaggcc ttgcagaatt tgggactctg ccatattctt      6420\r\n     tccgtctatt taaaaggatt ggattatgaa aataaagact ggtgtcctga actagaagaa      6480\r\n     cttcattacc aagcagcatg gaggaatatg cagtgggacc attgcacttc cgtcagcaaa      6540\r\n     gaagtagaag gaaccagtta ccatgaatca ttgtacaatg ctctacaatc tctaagagac      6600\r\n     agagaattct ctacatttta tgaaagtctc aaatatgcca gagtaaaaga agtggaagag      6660\r\n     atgtgtaagc gcagccttga gtctgtgtat tcgctctatc ccacacttag caggttgcag      6720\r\n     gccattggag agctggaaag cattggggag cttttctcaa gatcagtcac acatagacaa      6780\r\n     ctctctgaag tatatattaa gtggcagaaa cactcccagc ttctcaagga cagtgatttt      6840\r\n     agttttcagg agcctatcat ggctctacgc acagtcattt tggagatcct gatggaaaag      6900\r\n     gaaatggaca actcacaaag agaatgtatt aaggacattc tcaccaaaca ccttgtagaa      6960\r\n     ctctctatac tggccagaac tttcaagaac actcagctcc ctgaaagggc aatatttcaa      7020\r\n     attaaacagt acaattcagt tagctgtgga gtctctgagt ggcagctgga agaagcacaa      7080\r\n     gtattctggg caaaaaagga gcagagtctt gccctgagta ttctcaagca aatgatcaag      7140\r\n     aagttggatg ccagctgtgc agcgaacaat cccagcctaa aacttacata cacagaatgt      7200\r\n     ctgagggttt gtggcaactg gttagcagaa acgtgcttag aaaatcctgc ggtcatcatg      7260\r\n     cagacctatc tagaaaaggc agtagaagtt gctggaaatt atgatggaga aagtagtgat      7320\r\n     gagctaagaa atggaaaaat gaaggcattt ctctcattag cccggttttc agatactcaa      7380\r\n     taccaaagaa ttgaaaacta catgaaatca tcggaatttg aaaacaagca agctctcctg      7440\r\n     aaaagagcca aagaggaagt aggtctcctt agggaacata aaattcagac aaacagatac      7500\r\n     acagtaaagg ttcagcgaga gctggagttg gatgaattag ccctgcgtgc actgaaagag      7560\r\n     gatcgtaaac gcttcttatg taaagcagtt gaaaattata tcaactgctt attaagtgga      7620\r\n     gaagaacatg atatgtgggt attccggctt tgttccctct ggcttgaaaa ttctggagtt      7680\r\n     tctgaagtca atggcatgat gaagagagac ggaatgaaga ttccaacata taaatttttg      7740\r\n     cctcttatgt accaattggc tgctagaatg gggaccaaga tgatgggagg cctaggattt      7800\r\n     catgaagtcc tcaataatct aatctctaga atttcaatgg atcaccccca tcacactttg      7860\r\n     tttattatac tggccttagc aaatgcaaac agagatgaat ttctgactaa accagaggta      7920\r\n     gccagaagaa gcagaataac taaaaatgtg cctaaacaaa gctctcagct tgatgaggat      7980\r\n     cgaacagagg ctgcaaatag aataatatgt actatcagaa gtaggagacc tcagatggtc      8040\r\n     agaagtgttg aggcactttg tgatgcttat attatattag caaacttaga tgccactcag      8100\r\n     tggaagactc agagaaaagg cataaatatt ccagcagacc agccaattac taaacttaag      8160\r\n     aatttagaag atgttgttgt ccctactatg gaaattaagg tggaccacac aggagaatat      8220\r\n     ggaaatctgg tgactataca gtcatttaaa gcagaatttc gcttagcagg aggtgtaaat      8280\r\n     ttaccaaaaa taatagattg tgtaggttcc gatggcaagg agaggagaca gcttgttaag      8340\r\n     ggccgtgatg acctgagaca agatgctgtc atgcaacagg tcttccagat gtgtaataca      8400\r\n     ttactgcaga gaaacacgga aactaggaag aggaaattaa ctatctgtac ttataaggtg      8460\r\n     gttcccctct ctcagcgaag tggtgttctt gaatggtgca caggaactgt ccccattggt      8520\r\n     gaatttcttg ttaacaatga agatggtgct cataaaagat acaggccaaa tgatttcagt      8580\r\n     gcctttcagt gccaaaagaa aatgatggag gtgcaaaaaa agtcttttga agagaaatat      8640\r\n     gaagtcttca tggatgtttg ccaaaatttt caaccagttt tccgttactt ctgcatggaa      8700\r\n     aaattcttgg atccagctat ttggtttgag aagcgattgg cttatacgcg cagtgtagct      8760\r\n     acttcttcta ttgttggtta catacttgga cttggtgata gacatgtaca gaatatcttg      8820\r\n     ataaatgagc agtcagcaga acttgtacat atagatctag gtgttgcttt tgaacagggc      8880\r\n     aaaatccttc ctactcctga gacagttcct tttagactca ccagagatat tgtggatggc      8940\r\n     atgggcatta cgggtgttga aggtgtcttc agaagatgct gtgagaaaac catggaagtg      9000\r\n     atgagaaact ctcaggaaac tctgttaacc attgtagagg tccttctata tgatccactc      9060\r\n     tttgactgga ccatgaatcc tttgaaagct ttgtatttac agcagaggcc ggaagatgaa      9120\r\n     actgagcttc accctactct gaatgcagat gaccaagaat gcaaacgaaa tctcagtgat      9180\r\n     attgaccaga gtttcgacaa agtagctgaa cgtgtcttaa tgagactaca agagaaactg      9240\r\n     aaaggagtgg aagaaggcac tgtgctcagt gttggtggac aggtgaattt gctcatacag      9300\r\n     caggccatag accccaaaaa tctcagccga cttttcccag gatggaaagc ttgggtgtga      9360\r\n     tcttcagtat atgaattacc ctttc                                            9385\r\n//\r\n",rel_pat_hum_12_r122.dat
JB754054,EP2607483A1,"ID   JB754054; SV 1; linear; other DNA; PAT; SYN; 58 BP.\r\nXX\r\nAC   JB754054;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 359 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/359, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f4ec39440f4b5b826b168244b24103bb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..58\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence complementary to ATM mRNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 58 BP; 13 A; 13 C; 14 G; 18 T; 0 other;\r\n     ccgggccgtc aactagaaca tgatactcga gtatcatgtt ctagttgacg gctttttg          58\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754053,EP2607483A1,"ID   JB754053; SV 1; linear; other DNA; PAT; SYN; 58 BP.\r\nXX\r\nAC   JB754053;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 358 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/358, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 952762b4b25aaf5f8ccbc7f2a8f31d10.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..58\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence complementary to ATM mRNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 58 BP; 14 A; 12 C; 13 G; 19 T; 0 other;\r\n     ccgggccata attcagggta gtttactcga gtaaactacc ctgaattatg gctttttg          58\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754052,EP2607483A1,"ID   JB754052; SV 1; linear; other DNA; PAT; SYN; 58 BP.\r\nXX\r\nAC   JB754052;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 357 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/357, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dd9ec17f51a5c86493445d6e9159285a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..58\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence complementary to ATM mRNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 58 BP; 14 A; 12 C; 13 G; 19 T; 0 other;\r\n     ccggcgtgtc ttaatgagac tacaactcga gttgtagtct cattaagaca cgtttttg          58\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754051,EP2607483A1,"ID   JB754051; SV 1; linear; other DNA; PAT; SYN; 58 BP.\r\nXX\r\nAC   JB754051;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 356 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/356, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9a20bbe02a6873680e83af7bb82eb0cd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..58\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence complementary to ATM mRNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 58 BP; 13 A; 13 C; 14 G; 18 T; 0 other;\r\n     ccgggcactg aaagaggatc gtaaactcga gtttacgatc ctctttcagt gctttttg          58\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754050,EP2607483A1,"ID   JB754050; SV 1; linear; other DNA; PAT; SYN; 58 BP.\r\nXX\r\nAC   JB754050;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 355 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/355, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 02909357755934f377831e1d0811a5b1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..58\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence complementary to ATM mRNA""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 58 BP; 14 A; 12 C; 13 G; 19 T; 0 other;\r\n     ccggcctgcc aacatacttt aagtactcga gtacttaaag tatgttggca ggtttttg          58\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754049,EP2607483A1,"ID   JB754049; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754049;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 354 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/354, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ee98cec618366d4141a07b0a63bac48f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 6 G; 4 T; 0 other;\r\n     ctcaaactgt gggggcact                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754048,EP2607483A1,"ID   JB754048; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB754048;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 353 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/353, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3ec221155c4c489406430bac7f24cf6a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 5 C; 6 G; 3 T; 0 other;\r\n     ctcaaactgt gggggcac                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754047,EP2607483A1,"ID   JB754047; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754047;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 352 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/352, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e69720a22d6351a3f9b8c0f6d43a411b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 5 C; 6 G; 5 T; 0 other;\r\n     ctcaaactgt gggggcactt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754046,EP2607483A1,"ID   JB754046; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB754046;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 351 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/351, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 720c82b946b6220a02d0e7247a0d36a9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 5 A; 4 C; 6 G; 3 T; 0 other;\r\n     actcaaactg tgggggca                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754045,EP2607483A1,"ID   JB754045; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754045;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 350 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/350, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b276d037841c50183dfbbb46ee576ba6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 5 C; 6 G; 6 T; 0 other;\r\n     ctcaaactgt gggggcactt t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754044,EP2607483A1,"ID   JB754044; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB754044;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 349 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/349, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8116bd10fe20dfc855a9bb04170be7ea.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 6 C; 6 G; 7 T; 0 other;\r\n     ctcaaactgt gggggcactt tct                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754043,EP2607483A1,"ID   JB754043; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754043;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 348 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/348, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dbc53e38c5397148a7766af8e4aecb3b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 5 C; 6 G; 3 T; 0 other;\r\n     actcaaactg tgggggcac                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754042,EP2607483A1,"ID   JB754042; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754042;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 347 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/347, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6432a9663457e6683db897665984da27.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 6 C; 6 G; 6 T; 0 other;\r\n     ctcaaactgt gggggcactt tc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754041,EP2607483A1,"ID   JB754041; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB754041;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 346 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/346, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 138b6d325dcdfcefed5e59003ce3f594.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 5 A; 6 C; 6 G; 7 T; 0 other;\r\n     actcaaactg tgggggcact ttct                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754040,EP2607483A1,"ID   JB754040; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754040;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 345 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/345, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2c22da5e8cc937b7162ca8dfad099acc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 5 C; 6 G; 5 T; 0 other;\r\n     actcaaactg tgggggcact t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754039,EP2607483A1,"ID   JB754039; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB754039;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 344 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/344, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2250dc9ec701ab568a38e73b84967992.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 6 C; 6 G; 6 T; 0 other;\r\n     actcaaactg tgggggcact ttc                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754038,EP2607483A1,"ID   JB754038; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754038;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 343 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/343, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 83b5bdeaf529cd9f840f421b2ae60975.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 5 C; 6 G; 6 T; 0 other;\r\n     actcaaactg tgggggcact tt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754037,EP2607483A1,"ID   JB754037; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754037;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 342 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/342, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b7d30f3d56e0dd1c3c43492094a6d5cc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 2 A; 5 C; 5 G; 7 T; 0 other;\r\n     gtgccgccat cttttgagt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754036,EP2607483A1,"ID   JB754036; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB754036;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 341 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/341, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7c6a798dfadf00c28d50aaecab027ffa.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 3 A; 5 C; 6 G; 9 T; 0 other;\r\n     agtgccgcca tcttttgagt gtt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754035,EP2607483A1,"ID   JB754035; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754035;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 340 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/340, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e7f21ed669f8c9f1e24e392569674f50.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 2 A; 5 C; 5 G; 8 T; 0 other;\r\n     tgccgccatc ttttgagtgt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754034,EP2607483A1,"ID   JB754034; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754034;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 339 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/339, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b7a9058abfe54d1a0bde6abe1261e5a8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 2 A; 5 C; 6 G; 7 T; 0 other;\r\n     gtgccgccat cttttgagtg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754033,EP2607483A1,"ID   JB754033; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754033;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 338 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/338, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5a55130ba1180e85a158796ad11e1683.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 5 C; 6 G; 7 T; 0 other;\r\n     aagtgccgcc atcttttgag tg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754032,EP2607483A1,"ID   JB754032; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754032;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 337 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/337, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f9e8a991a1ec6cd0069373f224d7fb98.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 5 C; 5 G; 7 T; 0 other;\r\n     agtgccgcca tcttttgagt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754031,EP2607483A1,"ID   JB754031; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754031;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 336 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/336, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8101a5813fcdb52b7f33268fc0c7a43b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 5 C; 5 G; 7 T; 0 other;\r\n     aagtgccgcc atcttttgag t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754030,EP2607483A1,"ID   JB754030; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754030;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 335 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/335, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7491668565885e3d9a3f8803706dff7e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 2 A; 5 C; 6 G; 8 T; 0 other;\r\n     gtgccgccat cttttgagtg t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754029,EP2607483A1,"ID   JB754029; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754029;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 334 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/334, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1534fbf9316758b0ba4d50e50ed3325c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 3 A; 5 C; 6 G; 8 T; 0 other;\r\n     agtgccgcca tcttttgagt gt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754028,EP2607483A1,"ID   JB754028; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754028;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 333 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/333, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b42c47b349d0f5294608714f5c6e83e0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 5 C; 9 G; 3 T; 0 other;\r\n     gccctgaacg aggggtctgg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754027,EP2607483A1,"ID   JB754027; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754027;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 332 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/332, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7ba9bf74b9fb9d0ad0adbb66cedd4569.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 5 C; 9 G; 3 T; 0 other;\r\n     ccctgaacga ggggtctgga g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754026,EP2607483A1,"ID   JB754026; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754026;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 331 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/331, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d307b0ea127882b51aebb84b2b0cf1c6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 5 C; 10 G; 3 T; 0 other;\r\n     gccctgaacg aggggtctgg ag                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754025,EP2607483A1,"ID   JB754025; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754025;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 330 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/330, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cf133dbb28b5fa8fcb8abc94a4d1a49d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 7 C; 5 G; 5 T; 0 other;\r\n     tgactcctag tccagggctc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754024,EP2607483A1,"ID   JB754024; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754024;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 329 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/329, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 67e17ab3377e417446b496f7cfedd396.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 6 C; 5 G; 5 T; 0 other;\r\n     tgactcctag tccagggct                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754023,EP2607483A1,"ID   JB754023; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754023;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 328 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/328, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 43f135f90820bef532707522b5468897.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 7 C; 6 G; 5 T; 0 other;\r\n     tgactcctag tccagggctc g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754022,EP2607483A1,"ID   JB754022; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754022;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 327 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/327, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6016e22bbcd6a925ab979a817cbb6180.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 8 C; 5 G; 5 T; 0 other;\r\n     ctgactccta gtccagggct c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754021,EP2607483A1,"ID   JB754021; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754021;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 326 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/326, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b326df5dee3b3d72768f5b2b2477e003.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 7 C; 5 G; 4 T; 0 other;\r\n     ctgactccta gtccagggc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754020,EP2607483A1,"ID   JB754020; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754020;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 325 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/325, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e66dd552e4cd94defc6a3ad012631600.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 7 C; 5 G; 5 T; 0 other;\r\n     ctgactccta gtccagggct                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754019,EP2607483A1,"ID   JB754019; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB754019;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 324 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/324, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 80db5314e1511e4744cef35e0a9499d5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 3 A; 8 C; 7 G; 5 T; 0 other;\r\n     gctgactcct agtccagggc tcg                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754018,EP2607483A1,"ID   JB754018; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB754018;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 323 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/323, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4f58073183c9804e77af0f24266f8a0d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 3 A; 8 C; 7 G; 6 T; 0 other;\r\n     gctgactcct agtccagggc tcgt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754017,EP2607483A1,"ID   JB754017; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754017;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 322 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/322, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 369178b228af6d626b73957998177e3a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 6 C; 6 G; 4 T; 0 other;\r\n     gctgactcct agtccaggg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754016,EP2607483A1,"ID   JB754016; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB754016;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 321 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/321, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0b0ffd22247a7d15e57155ad53d6222c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 6 C; 5 G; 4 T; 0 other;\r\n     gctgactcct agtccagg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754015,EP2607483A1,"ID   JB754015; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754015;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 320 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/320, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c4223833d4542cad1bb14ffea21c0b3e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 7 C; 6 G; 4 T; 0 other;\r\n     gctgactcct agtccagggc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754014,EP2607483A1,"ID   JB754014; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754014;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 319 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/319, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 140154356a41f2006065dafe800b13ad.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 7 C; 6 G; 5 T; 0 other;\r\n     gctgactcct agtccagggc t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754013,EP2607483A1,"ID   JB754013; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754013;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 318 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/318, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 55038e6e059c1736ae3889c3c630f544.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 6 A; 3 C; 8 G; 5 T; 0 other;\r\n     tgtgaaactg ggctcaaggt ga                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754012,EP2607483A1,"ID   JB754012; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754012;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 317 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/317, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1861ec28c4bb2bbcdbffe4f16aad9454.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 3 C; 7 G; 4 T; 0 other;\r\n     tgaaactggg ctcaaggtg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754011,EP2607483A1,"ID   JB754011; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754011;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 316 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/316, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6d7783496a4ee9d15fc413a0bfb8aea8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 3 C; 6 G; 6 T; 0 other;\r\n     ctatctgtga ttgagggaca                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754010,EP2607483A1,"ID   JB754010; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB754010;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 315 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/315, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 200dd3063e85321ea00e75a825a3daea.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 2 C; 8 G; 7 T; 0 other;\r\n     ggtgctatct gtgattgagg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754009,EP2607483A1,"ID   JB754009; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB754009;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 314 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/314, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f6de87f22cf0e6e558b95606977eac26.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 5 C; 8 G; 5 T; 0 other;\r\n     cctgtgaaac tgggctcaag gtga                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754008,EP2607483A1,"ID   JB754008; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB754008;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 313 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/313, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a41dc49103f5ba1ff20fc9b88464fbd7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 3 C; 8 G; 4 T; 0 other;\r\n     gtgaaactgg gctcaaggtg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754007,EP2607483A1,"ID   JB754007; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754007;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 312 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/312, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; edc69f1bc136a2bf229b24c1466b0870.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 2 C; 6 G; 6 T; 0 other;\r\n     tatctgtgat tgagggaca                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754006,EP2607483A1,"ID   JB754006; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754006;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 311 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/311, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 94b4b5e6b2f32f5646cf83a2e0fc0353.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 2 C; 7 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattga                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754005,EP2607483A1,"ID   JB754005; SV 1; linear; other RNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JB754005;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 310 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/310, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d9fd2be83ed7f0a125c4c7b07c2d0cc1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 5 A; 3 C; 11 G; 8 T; 0 other;\r\n     ggggtgctat ctgtgattga gggacat                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754004,EP2607483A1,"ID   JB754004; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754004;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 309 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/309, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5f8560675e6eeadcc0b48529ab4cb235.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 2 C; 5 G; 7 T; 0 other;\r\n     catggttaat ggaattgtc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754003,EP2607483A1,"ID   JB754003; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB754003;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 308 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/308, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 29822245cdc265c8d854478798007336.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 2 A; 2 C; 7 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754002,EP2607483A1,"ID   JB754002; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB754002;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 307 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/307, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3f80dbb76e6676d1cc37917bbeed4c9e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 2 C; 7 G; 7 T; 0 other;\r\n     tgctatctgt gattgaggg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754001,EP2607483A1,"ID   JB754001; SV 1; linear; other RNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JB754001;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 306 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/306, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d2e67ebf86fd428e02f799c1d428f61b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 6 A; 3 C; 11 G; 8 T; 0 other;\r\n     aggggtgcta tctgtgattg agggacat                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754000,EP2607483A1,"ID   JB754000; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB754000;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 305 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/305, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b81006d9d8e05905bbb7c9888fae88be.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 3 C; 8 G; 7 T; 0 other;\r\n     gtgctatctg tgattgaggg ac                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753999,EP2607483A1,"ID   JB753999; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753999;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 304 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/304, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5da8babdbca34bc1d7bc790d1a9e6508.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 5 C; 8 G; 5 T; 0 other;\r\n     cctgtgaaac tgggctcaag gtg                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753998,EP2607483A1,"ID   JB753998; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753998;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 303 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/303, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c25d3786b250174292dc1e4c7b2a3b0b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 3 C; 7 G; 6 T; 0 other;\r\n     gctatctgtg attgagggac a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753997,EP2607483A1,"ID   JB753997; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753997;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 302 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/302, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6eeb14d50bdf7f323bf65693dc3bb7ed.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 2 A; 2 C; 8 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753996,EP2607483A1,"ID   JB753996; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753996;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 301 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/301, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3c6eb2787a0b08aaa9f2781f203550d5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 2 C; 8 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753995,EP2607483A1,"ID   JB753995; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753995;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 300 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/300, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9db4f75fc0b985cfe78735a298bd90d9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 3 C; 8 G; 4 T; 0 other;\r\n     gtgaaactgg gctcaaggtg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753994,EP2607483A1,"ID   JB753994; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753994;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 299 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/299, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e11041e1a5e8714085ae678512145c01.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 3 C; 9 G; 7 T; 0 other;\r\n     ggtgctatct gtgattgagg gac                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753993,EP2607483A1,"ID   JB753993; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753993;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 298 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/298, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 198d888172432ec4d9a7bde0167efe93.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 6 A; 4 C; 8 G; 5 T; 0 other;\r\n     ctgtgaaact gggctcaagg tga                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753992,EP2607483A1,"ID   JB753992; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753992;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 297 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/297, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 38d7374a41a29d7cefbaaef3caa189ce.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 3 C; 7 G; 8 T; 0 other;\r\n     tgctatctgt gattgaggga cat                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753991,EP2607483A1,"ID   JB753991; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753991;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 296 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/296, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6e9efd3a4640cdf2b0b663592bb339d6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 2 C; 9 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753990,EP2607483A1,"ID   JB753990; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753990;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 295 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/295, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f26f29de268bea54bdc77d7ad4bc5157.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 2 C; 8 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753989,EP2607483A1,"ID   JB753989; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753989;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 294 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/294, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5a37cb29aa7895a1c8cd64eec9b4bf15.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 4 C; 8 G; 5 T; 0 other;\r\n     ctgtgaaact gggctcaagg tg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753988,EP2607483A1,"ID   JB753988; SV 1; linear; other RNA; PAT; SYN; 26 BP.\r\nXX\r\nAC   JB753988;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 293 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/293, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c74678445b8b66e9a1cbecf491d4b28c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..26\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 26 BP; 5 A; 3 C; 11 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg agggac                                             26\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753987,EP2607483A1,"ID   JB753987; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753987;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 292 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/292, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 40327c34b59c9d3d5a7253b1328697ed.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 5 A; 3 C; 10 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag ggaca                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753986,EP2607483A1,"ID   JB753986; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753986;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 291 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/291, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0b133112fd9ef0ee7da7e2876e0b9670.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 2 C; 7 G; 7 T; 0 other;\r\n     tgctatctgt gattgaggga                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753985,EP2607483A1,"ID   JB753985; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753985;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 290 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/290, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b34bfe95fa949bb29943c3d2549d3f53.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 2 C; 9 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753984,EP2607483A1,"ID   JB753984; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753984;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 289 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/289, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a20a837e3beb71f33c9135117174ef9a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 3 A; 2 C; 10 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag gg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753983,EP2607483A1,"ID   JB753983; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753983;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 288 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/288, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5f1491abb1408a7381c8b530bd3b93c0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 2 C; 9 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg ag                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753982,EP2607483A1,"ID   JB753982; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753982;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 287 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/287, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 47cc64f07c7125d31b5d59e2541d3517.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 4 A; 3 C; 10 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag ggac                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753981,EP2607483A1,"ID   JB753981; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753981;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 286 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/286, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 58d4bf0786d5f388e3515ab9bb67f397.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 4 A; 2 C; 11 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg aggg                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753980,EP2607483A1,"ID   JB753980; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753980;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 285 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/285, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7be6ae7cf7559ad10ad0d7ef825302b1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 2 C; 10 G; 7 T; 0 other;\r\n     gggtgctatc tgtgattgag gga                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753979,EP2607483A1,"ID   JB753979; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753979;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 284 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/284, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ade27db1893456c967946b13bee1347a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 3 C; 7 G; 7 T; 0 other;\r\n     tgctatctgt gattgaggga c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753978,EP2607483A1,"ID   JB753978; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753978;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 283 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/283, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; bd32098eb71bd371eb3fd848eb9c68dd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 2 C; 8 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753977,EP2607483A1,"ID   JB753977; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753977;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 282 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/282, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c4e9abde10147c96b537265e70426964.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 5 A; 2 C; 11 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg aggga                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753976,EP2607483A1,"ID   JB753976; SV 1; linear; other RNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JB753976;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 281 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/281, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 50f7cc1809099669cdfedfde31b8d520.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 6 A; 3 C; 11 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg agggaca                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753975,EP2607483A1,"ID   JB753975; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753975;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 280 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/280, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fab614af532d2f4884029ff3d18098c2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 3 A; 2 C; 11 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga ggg                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753974,EP2607483A1,"ID   JB753974; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753974;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 279 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/279, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; afe87db422c821b34dde5567c9d2f2b0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 2 C; 10 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg agg                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753973,EP2607483A1,"ID   JB753973; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753973;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 278 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/278, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3bb394d1ac8f196ac52e7b1c46677341.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 3 C; 7 G; 7 T; 0 other;\r\n     tgctatctgt gattgaggga ca                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753972,EP2607483A1,"ID   JB753972; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753972;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 277 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/277, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f8a0f23ceb47baa9c0fa15b4a316c401.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""isomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 3 A; 2 C; 10 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga gg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753971,EP2607483A1,"ID   JB753971; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753971;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 276 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/276, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 553c11ebff302270796d0567a5903339.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 4 A; 2 C; 11 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga ggga                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753970,EP2607483A1,"ID   JB753970; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753970;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 275 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/275, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 413c066636dfdefbf69e389341d8c1b7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 4 A; 3 C; 11 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga gggac                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753969,EP2607483A1,"ID   JB753969; SV 1; linear; other RNA; PAT; SYN; 26 BP.\r\nXX\r\nAC   JB753969;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 274 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/274, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ab4366105b2b6025b42d27815f85eedc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..26\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 26 BP; 5 A; 3 C; 11 G; 7 T; 0 other;\r\n     ggggtgctat ctgtgattga gggaca                                             26\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753968,EP2607483A1,"ID   JB753968; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753968;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 273 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/273, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 41dca0e4bf0067fca8af6ad9a4bf5577.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 6 A; 8 C; 3 G; 2 T; 0 other;\r\n     cacagaaatc gcacccgtc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753967,EP2607483A1,"ID   JB753967; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753967;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 272 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/272, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f73970eadbbbf1d34ce240b520764b38.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 7 A; 7 C; 2 G; 2 T; 0 other;\r\n     tcacacagaa atcgcacc                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753966,EP2607483A1,"ID   JB753966; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753966;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 271 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/271, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1feae27a2e1a488810d964a57bc3436d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 8 A; 10 C; 3 G; 3 T; 0 other;\r\n     tcacacagaa atcgcacccg tcac                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753965,EP2607483A1,"ID   JB753965; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753965;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 270 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/270, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 164907e4650cf37ddc56a83b08bac74a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 6 A; 7 C; 3 G; 2 T; 0 other;\r\n     cacagaaatc gcacccgt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753964,EP2607483A1,"ID   JB753964; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753964;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 269 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/269, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 677bc96b1f06e4dc649793ce2d5ab16b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 8 A; 8 C; 3 G; 2 T; 0 other;\r\n     acacagaaat cgcacccgtc a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753963,EP2607483A1,"ID   JB753963; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753963;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 268 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/268, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fd47aa493f64448e6a1718fe96a43c9b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 9 C; 3 G; 3 T; 0 other;\r\n     gtctcacaca gaaatcgcac cc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753962,EP2607483A1,"ID   JB753962; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753962;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 267 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/267, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a389075856fe9ddebd744053dbab8177.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 7 A; 6 C; 2 G; 3 T; 0 other;\r\n     tctcacacag aaatcgca                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753961,EP2607483A1,"ID   JB753961; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753961;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 266 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/266, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 38731b7b54e65d40913c7156307b9bcd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 7 A; 8 C; 2 G; 2 T; 0 other;\r\n     tcacacagaa atcgcaccc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753960,EP2607483A1,"ID   JB753960; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753960;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 265 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/265, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 15f95569d016860e36b0458e4389e1f8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 7 A; 7 C; 3 G; 2 T; 0 other;\r\n     acagaaatcg cacccgtca                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753959,EP2607483A1,"ID   JB753959; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753959;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 264 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/264, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 182bea0d8ca58cb0725c7ed528dbbc37.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 6 A; 7 C; 3 G; 2 T; 0 other;\r\n     acagaaatcg cacccgtc                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753958,EP2607483A1,"ID   JB753958; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753958;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 263 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/263, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6c045e7b0a582846b98f7adf7d747a9d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 9 C; 2 G; 2 T; 0 other;\r\n     ctcacacaga aatcgcaccc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753957,EP2607483A1,"ID   JB753957; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753957;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 262 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/262, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 52346c012aa2158f4d6f88dde17c4a5b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 8 C; 3 G; 2 T; 0 other;\r\n     cacacagaaa tcgcacccgt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753956,EP2607483A1,"ID   JB753956; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753956;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 261 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/261, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; bf98cdc3acfc41179dcabb167710ddea.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 7 A; 7 C; 3 G; 2 T; 0 other;\r\n     acacagaaat cgcacccgt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753955,EP2607483A1,"ID   JB753955; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753955;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 260 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/260, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b861b3f8f788a2d1ba554dfcb252cabe.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 7 A; 9 C; 3 G; 2 T; 0 other;\r\n     cacacagaaa tcgcacccgt c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753954,EP2607483A1,"ID   JB753954; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753954;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 259 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/259, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3ef9b3f2e2215e6c6c8e098b167c8a9c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 7 A; 7 C; 2 G; 3 T; 0 other;\r\n     tctcacacag aaatcgcac                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753953,EP2607483A1,"ID   JB753953; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753953;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 258 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/258, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0f1c057aeb0fe65cdba4cde92730e78d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 8 A; 10 C; 3 G; 3 T; 0 other;\r\n     ctcacacaga aatcgcaccc gtca                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753952,EP2607483A1,"ID   JB753952; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753952;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 257 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/257, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 698eed77909cbb409a40b0834db3c027.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 7 A; 9 C; 3 G; 2 T; 0 other;\r\n     ctcacacaga aatcgcaccc g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753951,EP2607483A1,"ID   JB753951; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753951;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 256 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/256, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 90c428d61c6e0012fbdbaaff4659dfa0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 8 C; 3 G; 2 T; 0 other;\r\n     tcacacagaa atcgcacccg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753950,EP2607483A1,"ID   JB753950; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753950;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 255 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/255, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c2636e42021458e53fa1b30ecab2643c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 8 A; 9 C; 3 G; 2 T; 0 other;\r\n     cacacagaaa tcgcacccgt ca                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753949,EP2607483A1,"ID   JB753949; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753949;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 254 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/254, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5eb97ee0d88c24e7fd3bb231ad585e4f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 7 A; 10 C; 3 G; 3 T; 0 other;\r\n     ctcacacaga aatcgcaccc gtc                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753948,EP2607483A1,"ID   JB753948; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753948;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 253 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/253, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5fc76d4553daa7caf7b28fb4b3d70dc8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 7 A; 9 C; 2 G; 3 T; 0 other;\r\n     tctcacacag aaatcgcacc c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753947,EP2607483A1,"ID   JB753947; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753947;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 252 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/252, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; bffe49780fd7bca08510d10413dd7ead.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 9 C; 3 G; 3 T; 0 other;\r\n     ctcacacaga aatcgcaccc gt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753946,EP2607483A1,"ID   JB753946; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753946;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 251 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/251, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2516df41aba5680279774ab116a8d087.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 7 A; 8 C; 3 G; 3 T; 0 other;\r\n     tcacacagaa atcgcacccg t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753945,EP2607483A1,"ID   JB753945; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753945;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 250 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/250, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6b1b4344bea29a8d744f61f85581c62c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 9 C; 3 G; 3 T; 0 other;\r\n     tcacacagaa atcgcacccg tc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753944,EP2607483A1,"ID   JB753944; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753944;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 249 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/249, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cb73a255d664153162e0f4068dbdae44.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 8 C; 2 G; 3 T; 0 other;\r\n     tctcacacag aaatcgcacc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753943,EP2607483A1,"ID   JB753943; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753943;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 248 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/248, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1c1269d0e2d80d0b158c60c791d044fa.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 8 A; 10 C; 3 G; 4 T; 0 other;\r\n     tctcacacag aaatcgcacc cgtca                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753942,EP2607483A1,"ID   JB753942; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753942;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 247 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/247, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 32ad63620376dcc0f5bf32ad7ceb2ec7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 8 A; 9 C; 3 G; 3 T; 0 other;\r\n     tcacacagaa atcgcacccg tca                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753941,EP2607483A1,"ID   JB753941; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753941;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 246 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/246, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dbf24bc9f1c4d4b7d6caefc0dd86e571.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 9 C; 3 G; 3 T; 0 other;\r\n     tctcacacag aaatcgcacc cg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753940,EP2607483A1,"ID   JB753940; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753940;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 245 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/245, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 041e3d6cda284a238e896e2189e32ef6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 7 A; 10 C; 3 G; 4 T; 0 other;\r\n     tctcacacag aaatcgcacc cgtc                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753939,EP2607483A1,"ID   JB753939; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753939;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 244 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/244, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2e78e894bc2f1aa3d863a73a64dbec3d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 8 C; 5 G; 3 T; 0 other;\r\n     ccccgaggcg gattcaccat                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753938,EP2607483A1,"ID   JB753938; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753938;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 243 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/243, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fc82e3a0f316ddc3d8cfe57e69f055e3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 2 A; 5 C; 6 G; 7 T; 0 other;\r\n     agcctcatct gtctgttggg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753937,EP2607483A1,"ID   JB753937; SV 1; linear; other RNA; PAT; SYN; 26 BP.\r\nXX\r\nAC   JB753937;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 242 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/242, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4bdefcde9fe2aaedca73836641be831b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..26\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 26 BP; 4 A; 4 C; 14 G; 4 T; 0 other;\r\n     ggaggcaggg cctttgtgaa ggcggg                                             26\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753936,EP2607483A1,"ID   JB753936; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753936;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 241 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/241, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d039e98d9218071d9efcb9f0d69f0c64.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 1 A; 5 C; 6 G; 7 T; 0 other;\r\n     gcctcatctg tctgttggg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753935,EP2607483A1,"ID   JB753935; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753935;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 240 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/240, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d06bff4c04df20c57f19eecc119828a9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 3 C; 11 G; 5 T; 0 other;\r\n     gtgaaggcgg gtggtgctca gat                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753934,EP2607483A1,"ID   JB753934; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753934;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 239 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/239, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d1ed680bed36f40bc58b97ad567a096e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 1 A; 6 C; 5 G; 7 T; 0 other;\r\n     cctcatctgt ctgttgggc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753933,EP2607483A1,"ID   JB753933; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753933;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 238 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/238, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6b6d0368e9ecd8ac2db696e7e582af71.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 1 A; 6 C; 6 G; 7 T; 0 other;\r\n     gcctcatctg tctgttgggc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753932,EP2607483A1,"ID   JB753932; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753932;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 237 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/237, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b255755c5faa5165fc0dff163dc87063.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 8 C; 5 G; 2 T; 0 other;\r\n     ccccgaggcg gattcacc                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753931,EP2607483A1,"ID   JB753931; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753931;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 236 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/236, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 77d834b7f1977207d96b7ef4d91ea8db.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 1 A; 11 C; 4 G; 5 T; 0 other;\r\n     cctctgggcc cttcctccag c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753930,EP2607483A1,"ID   JB753930; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753930;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 235 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/235, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b5d9ed456bc04c786d790a26e5f7c99c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 8 C; 7 G; 3 T; 0 other;\r\n     ccccgaggcg gattcaccat gag                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753929,EP2607483A1,"ID   JB753929; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753929;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 234 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/234, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0f1e430b9e16465be5c08cc20fa83651.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 1 A; 4 C; 5 G; 8 T; 0 other;\r\n     tcatctgtct gttgggct                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753928,EP2607483A1,"ID   JB753928; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753928;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 233 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/233, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0616dd40c2f231038a45feaf8990fdfa.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 1 A; 5 C; 5 G; 8 T; 0 other;\r\n     ctcatctgtc tgttgggct                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753927,EP2607483A1,"ID   JB753927; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753927;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 232 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/232, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 463667396316137ebe725937d34453eb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 2 A; 6 C; 6 G; 8 T; 0 other;\r\n     agcctcatct gtctgttggg ct                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753926,EP2607483A1,"ID   JB753926; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753926;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 231 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/231, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c315f79a7ca99ffe760215c6b8831f19.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 1 A; 6 C; 5 G; 8 T; 0 other;\r\n     cctcatctgt ctgttgggct                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753925,EP2607483A1,"ID   JB753925; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753925;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 230 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/230, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e5a07eac818fee4b6fcea56a849ffe46.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 1 A; 6 C; 6 G; 8 T; 0 other;\r\n     gcctcatctg tctgttgggc t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753924,EP2607483A1,"ID   JB753924; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753924;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 229 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/229, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7a76473ce2702f50080a38a2924feb72.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 1 A; 4 C; 10 G; 5 T; 0 other;\r\n     gaggtggtcc gtggcgcgtt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753923,EP2607483A1,"ID   JB753923; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753923;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 228 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/228, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 93d40f63952420f59aee369f82c310ae.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 1 A; 4 C; 9 G; 4 T; 0 other;\r\n     aggtggtccg tggcgcgt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753922,EP2607483A1,"ID   JB753922; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753922;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 227 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/227, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8b2cc234505ffbc1ff714d4f81751f60.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 0 A; 4 C; 9 G; 5 T; 0 other;\r\n     ggtggtccgt ggcgcgtt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753921,EP2607483A1,"ID   JB753921; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753921;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 226 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/226, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5fdd5ca95d9698a815097ba037a59c9b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 1 A; 6 C; 10 G; 6 T; 0 other;\r\n     aggtggtccg tggcgcgttc gct                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753920,EP2607483A1,"ID   JB753920; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753920;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 225 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/225, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f1bcb701aa8588ae8cc5f00dee241d15.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 1 A; 5 C; 10 G; 5 T; 0 other;\r\n     gaggtggtcc gtggcgcgtt c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753919,EP2607483A1,"ID   JB753919; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753919;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 224 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/224, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 38d4ccf5561436e7830dfe4cc0573166.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 3 C; 8 G; 7 T; 0 other;\r\n     tgctgcttgg tacttggaga g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753918,EP2607483A1,"ID   JB753918; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753918;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 223 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/223, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 188d232d12a9736ec754498c30de4a92.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 3 C; 7 G; 6 T; 0 other;\r\n     ctgcttggta cttggagag                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753917,EP2607483A1,"ID   JB753917; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753917;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 222 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/222, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ca9c88f4a3b5f27720088c8bcde074ac.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 1 A; 4 C; 9 G; 5 T; 0 other;\r\n     aggtggtccg tggcgcgtt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753916,EP2607483A1,"ID   JB753916; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753916;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 221 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/221, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 71363a4562ef993f62942c30392dcc5c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 3 C; 8 G; 6 T; 0 other;\r\n     gctgcttggt acttggagag                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753915,EP2607483A1,"ID   JB753915; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753915;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 220 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/220, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3f8a8bdae0b05eb0ad6e70a1dd17f6a7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 1 A; 5 C; 10 G; 5 T; 0 other;\r\n     aggtggtccg tggcgcgttc g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753914,EP2607483A1,"ID   JB753914; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753914;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 219 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/219, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dbb37219861180c9624624765eb37538.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 1 A; 5 C; 9 G; 5 T; 0 other;\r\n     aggtggtccg tggcgcgttc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753913,EP2607483A1,"ID   JB753913; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753913;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 218 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/218, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; bb53b142aeb7993578f84bde5f63f089.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 9 C; 4 G; 5 T; 0 other;\r\n     cgcacattac acggtcgacc tct                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753912,EP2607483A1,"ID   JB753912; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753912;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 217 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/217, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4c7ffc59179756da66e989f15984f241.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 6 C; 5 G; 6 T; 0 other;\r\n     ttatggcgca cattacacgg tc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753911,EP2607483A1,"ID   JB753911; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753911;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 216 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/216, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5a2adcd44d909151afbd081cba4e8fba.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 7 C; 3 G; 5 T; 0 other;\r\n     cattacacgg tcgacctct                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753910,EP2607483A1,"ID   JB753910; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753910;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 215 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/215, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b0d06b66a5a99c29f70d548e497d560e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 5 A; 7 C; 3 G; 3 T; 0 other;\r\n     cacattacac ggtcgacc                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753909,EP2607483A1,"ID   JB753909; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753909;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 214 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/214, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 659806b9bca744024e8bcea92adcafca.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 5 A; 8 C; 4 G; 7 T; 0 other;\r\n     gcacattaca cggtcgacct cttt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753908,EP2607483A1,"ID   JB753908; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753908;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 213 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/213, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e66254d70c0b3899093e8331aab48515.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 7 C; 3 G; 4 T; 0 other;\r\n     cacattacac ggtcgacct                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753907,EP2607483A1,"ID   JB753907; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753907;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 212 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/212, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d7a09f6c9d83ef1e389a048817f86fb4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 5 A; 6 C; 4 G; 3 T; 0 other;\r\n     gcacattaca cggtcgac                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753906,EP2607483A1,"ID   JB753906; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753906;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 211 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/211, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1c20e556d98be0f7df2d832499b1b683.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 8 C; 3 G; 6 T; 0 other;\r\n     cacattacac ggtcgacctc tt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753905,EP2607483A1,"ID   JB753905; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753905;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 210 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/210, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 53640b9041d7a11cc879d6eb7e725657.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 5 A; 8 C; 5 G; 7 T; 0 other;\r\n     gcacattaca cggtcgacct ctttg                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753904,EP2607483A1,"ID   JB753904; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753904;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 209 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/209, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 082da01be1e4283b4a69aa345b18da8d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 7 C; 4 G; 3 T; 0 other;\r\n     gcacattaca cggtcgacc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753903,EP2607483A1,"ID   JB753903; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753903;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 208 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/208, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7f16522c85dae917d252c412a0a826a6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 7 C; 3 G; 5 T; 0 other;\r\n     acattacacg gtcgacctct                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753902,EP2607483A1,"ID   JB753902; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753902;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 207 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/207, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 26ab78ff256be55df40fb7c2e569f109.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 8 C; 3 G; 4 T; 0 other;\r\n     cacattacac ggtcgacctc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753901,EP2607483A1,"ID   JB753901; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753901;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 206 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/206, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 017c0887801c27e6ef9f43aebb9678f3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 8 C; 4 G; 6 T; 0 other;\r\n     gcacattaca cggtcgacct ctt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753900,EP2607483A1,"ID   JB753900; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753900;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 205 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/205, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1a1656c78047347c0fcf8e507178a81a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 8 C; 4 G; 4 T; 0 other;\r\n     gcacattaca cggtcgacct c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753899,EP2607483A1,"ID   JB753899; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753899;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 204 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/204, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cb361ae934c2d333c63f8763f952469d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 7 C; 4 G; 4 T; 0 other;\r\n     gcacattaca cggtcgacct                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753898,EP2607483A1,"ID   JB753898; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753898;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 203 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/203, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; da82be92e9fbc8fa81c701621c379378.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 8 C; 4 G; 5 T; 0 other;\r\n     gcacattaca cggtcgacct ct                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753897,EP2607483A1,"ID   JB753897; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753897;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 202 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/202, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4e906f2977abaade4dd0fee59e650531.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 5 A; 8 C; 5 G; 7 T; 0 other;\r\n     accactgacc gttgactgta ccttg                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753896,EP2607483A1,"ID   JB753896; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753896;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 201 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/201, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c4f08ea579ee0898679e42bd85a478c4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 10 A; 6 C; 4 G; 5 T; 0 other;\r\n     aaaaaaccac tgaccgttga ctgta                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753895,EP2607483A1,"ID   JB753895; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753895;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 200 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/200, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a96893a3e58ae8183d80451b240204fa.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 6 C; 4 G; 4 T; 0 other;\r\n     aaccactgac cgttgactg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753894,EP2607483A1,"ID   JB753894; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753894;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 199 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/199, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 731a78b6ea3fee572cd054320853b4d6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 9 A; 6 C; 4 G; 5 T; 0 other;\r\n     aaaaaaccac tgaccgttga ctgt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753893,EP2607483A1,"ID   JB753893; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753893;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 198 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/198, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6fbb8f41c17043c5c13ace97092a1f32.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 9 A; 6 C; 5 G; 5 T; 0 other;\r\n     gaaaaaacca ctgaccgttg actgt                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753892,EP2607483A1,"ID   JB753892; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753892;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 197 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/197, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c315e1f80cfcc11ec81c403979eb654f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 7 C; 4 G; 5 T; 0 other;\r\n     cactgaccgt tgactgtacc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753891,EP2607483A1,"ID   JB753891; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753891;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 196 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/196, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2bb2aaa0d25d04a302b842479c6c1ffc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 8 C; 4 G; 6 T; 0 other;\r\n     ccactgaccg ttgactgtac ct                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753890,EP2607483A1,"ID   JB753890; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753890;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 195 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/195, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fe7140b2d480db0f5cc67a49c8f2eb44.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 5 C; 4 G; 5 T; 0 other;\r\n     actgaccgtt gactgtac                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753889,EP2607483A1,"ID   JB753889; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753889;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 194 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/194, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5294491dad9ebc3284597c5daa0c7b15.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 6 C; 4 G; 5 T; 0 other;\r\n     actgaccgtt gactgtacc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753888,EP2607483A1,"ID   JB753888; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753888;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 193 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/193, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4e4676c614d0683be1b23ee5970c4a2b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 5 C; 6 G; 5 T; 0 other;\r\n     ttggggtcct tacagacgac a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753887,EP2607483A1,"ID   JB753887; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753887;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 192 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/192, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0e5b4a692073c58785af529d76386357.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 6 C; 4 G; 5 T; 0 other;\r\n     ccactgaccg ttgactgta                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753886,EP2607483A1,"ID   JB753886; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753886;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 191 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/191, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 268c983692aa56fdd609cc4e9c78dc95.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 8 C; 4 G; 6 T; 0 other;\r\n     aaccactgac cgttgactgt acct                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753885,EP2607483A1,"ID   JB753885; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753885;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 190 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/190, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 39a5965d8c37e922831ba11aa549e839.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 5 C; 4 G; 5 T; 0 other;\r\n     cactgaccgt tgactgta                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753884,EP2607483A1,"ID   JB753884; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753884;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 189 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/189, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 96dc1b29aa3fd95a71f6d24f0a796792.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 6 C; 4 G; 5 T; 0 other;\r\n     cactgaccgt tgactgtac                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753883,EP2607483A1,"ID   JB753883; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753883;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 188 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/188, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d856205bc5e54ada41a9a3c0cc8b4854.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 8 C; 4 G; 5 T; 0 other;\r\n     ccactgaccg ttgactgtac c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753882,EP2607483A1,"ID   JB753882; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753882;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 187 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/187, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ce6f67a0d1a24b2c92e8945b91633fa1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 6 A; 8 C; 4 G; 5 T; 0 other;\r\n     aaccactgac cgttgactgt acc                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753881,EP2607483A1,"ID   JB753881; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753881;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 186 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/186, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b34f0fe133a8e9dc2ebd0373986468ef.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 6 C; 4 G; 4 T; 0 other;\r\n     accactgacc gttgactg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753880,EP2607483A1,"ID   JB753880; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753880;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 185 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/185, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ed8a65e7e8e9f9f2f3efa843bbc9e62a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 7 C; 4 G; 5 T; 0 other;\r\n     ccactgaccg ttgactgtac                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753879,EP2607483A1,"ID   JB753879; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753879;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 184 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/184, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f3e1bb992c2d818646f1ab3d98f641d6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 8 C; 4 G; 6 T; 0 other;\r\n     accactgacc gttgactgta cct                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753878,EP2607483A1,"ID   JB753878; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753878;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 183 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/183, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cffb90d34845c44625291872ec579d68.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 6 C; 4 G; 5 T; 0 other;\r\n     aaccactgac cgttgactgt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753877,EP2607483A1,"ID   JB753877; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753877;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 182 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/182, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 078666a27853220d9a9f43e8e7c0ed50.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 6 C; 4 G; 5 T; 0 other;\r\n     aaccactgac cgttgactgt a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753876,EP2607483A1,"ID   JB753876; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753876;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 181 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/181, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dcc29c58025577dd1e27f9270e4877c6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 6 A; 7 C; 4 G; 5 T; 0 other;\r\n     aaccactgac cgttgactgt ac                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753875,EP2607483A1,"ID   JB753875; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753875;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 180 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/180, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9549d340a9b5e62e4d576ed9acfa4c86.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 6 C; 4 G; 5 T; 0 other;\r\n     accactgacc gttgactgt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753874,EP2607483A1,"ID   JB753874; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753874;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 179 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/179, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e9b64d2180c4202516309a70f321b57a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 6 C; 4 G; 5 T; 0 other;\r\n     accactgacc gttgactgta                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753873,EP2607483A1,"ID   JB753873; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753873;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 178 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/178, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c71fe0e409b2597ac1c05adf49bd2017.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 7 C; 4 G; 5 T; 0 other;\r\n     accactgacc gttgactgta c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753872,EP2607483A1,"ID   JB753872; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753872;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 177 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/177, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 95d2dd55b387c188a3a613f83e25682e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 6 A; 5 C; 3 G; 4 T; 0 other;\r\n     aaaccatcga ccgttgat                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753871,EP2607483A1,"ID   JB753871; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753871;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 176 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/176, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e7294bdace6674ad28bdb7f6cf1b2a48.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 6 A; 5 C; 4 G; 5 T; 0 other;\r\n     aaaccatcga ccgttgattg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753870,EP2607483A1,"ID   JB753870; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753870;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 175 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/175, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a096bd719f2c1c8105e3b02e8ae33ea6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 5 C; 4 G; 5 T; 0 other;\r\n     aaccatcgac cgttgattg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753869,EP2607483A1,"ID   JB753869; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753869;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 174 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/174, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3d87c3135a1d267c86ae5b3d9c25c91a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 8 A; 6 C; 4 G; 7 T; 0 other;\r\n     tcaaaaccat cgaccgttga ttgta                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753868,EP2607483A1,"ID   JB753868; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753868;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 173 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/173, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e0ad0c456a6e0cdbf6a16b5086349f34.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 8 A; 6 C; 3 G; 4 T; 0 other;\r\n     atcaaaacca tcgaccgttg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753867,EP2607483A1,"ID   JB753867; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753867;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 172 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/172, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d5a5422eaf876e025ce09a5a8c2cd872.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 4 G; 6 T; 0 other;\r\n     atcgaccgtt gattgtacc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753866,EP2607483A1,"ID   JB753866; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753866;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 171 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/171, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 791622483aed93e39b91e7a1911073c0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 6 C; 4 G; 6 T; 0 other;\r\n     ccatcgaccg ttgattgtac                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753865,EP2607483A1,"ID   JB753865; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753865;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 170 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/170, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 161e21dbaba09cab18e2eba863c9de15.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 5 C; 4 G; 6 T; 0 other;\r\n     aaaaccatcg accgttgatt gt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753864,EP2607483A1,"ID   JB753864; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753864;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 169 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/169, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2cf701ebaa8fec9ea5506155d5838201.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 4 G; 6 T; 0 other;\r\n     ccatcgaccg ttgattgta                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753863,EP2607483A1,"ID   JB753863; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753863;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 168 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/168, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9fc38695fc9999b672fd516a35567c02.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 7 C; 4 G; 6 T; 0 other;\r\n     ccatcgaccg ttgattgtac c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753862,EP2607483A1,"ID   JB753862; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753862;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 167 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/167, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 02bdf998f8a9973c412dba7fe8f1a1fd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 7 A; 6 C; 4 G; 6 T; 0 other;\r\n     aaaccatcga ccgttgattg tac                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753861,EP2607483A1,"ID   JB753861; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753861;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 166 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/166, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 91beb6e7a6a98b00c050af3acf3a7885.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 5 C; 4 G; 6 T; 0 other;\r\n     aaaccatcga ccgttgattg t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753860,EP2607483A1,"ID   JB753860; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753860;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 165 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/165, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0236b0e7bd3fe9b0826e4978b1dbbcca.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 6 A; 6 C; 4 G; 6 T; 0 other;\r\n     aaccatcgac cgttgattgt ac                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753859,EP2607483A1,"ID   JB753859; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753859;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 164 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/164, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 69c91e469d27ceb0bb6f59bdbc1162b0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 5 C; 4 G; 5 T; 0 other;\r\n     accatcgacc gttgattg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753858,EP2607483A1,"ID   JB753858; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753858;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 163 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/163, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b36eb4e30e74177e24403dee27c6ec59.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 4 G; 6 T; 0 other;\r\n     aaccatcgac cgttgattgt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753857,EP2607483A1,"ID   JB753857; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753857;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 162 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/162, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f85ca9055d37814ad61dd0d0c60aafb9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 7 A; 5 C; 4 G; 6 T; 0 other;\r\n     aaaccatcga ccgttgattg ta                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753856,EP2607483A1,"ID   JB753856; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753856;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 161 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/161, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4cba01ac0ece9340184fb72b39df7bab.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 5 C; 4 G; 6 T; 0 other;\r\n     aaccatcgac cgttgattgt a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753855,EP2607483A1,"ID   JB753855; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753855;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 160 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/160, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 25be9a75bd55d651aacc9a1f2aadaa70.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 4 G; 6 T; 0 other;\r\n     accatcgacc gttgattgt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753854,EP2607483A1,"ID   JB753854; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753854;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 159 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/159, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f9f111b140a7f4479482ede352e84ca4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 6 C; 4 G; 6 T; 0 other;\r\n     accatcgacc gttgattgta c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753853,EP2607483A1,"ID   JB753853; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753853;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 158 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/158, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f95a891acc125dc5cd86af33f5ccae39.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 4 G; 6 T; 0 other;\r\n     accatcgacc gttgattgta                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753852,EP2607483A1,"ID   JB753852; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753852;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 157 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/157, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7f8541fe88d2214f47e0459aeb681cbb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 6 A; 8 C; 8 G; 3 T; 0 other;\r\n     ggccagcctt cagaggactc caagg                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753851,EP2607483A1,"ID   JB753851; SV 1; linear; other RNA; PAT; SYN; 29 BP.\r\nXX\r\nAC   JB753851;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 156 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/156, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f189ef994b7da50e643825b350b85f98.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..29\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 29 BP; 7 A; 5 C; 9 G; 8 T; 0 other;\r\n     aacattcaac gctgtcggtg agtttggga                                          29\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753850,EP2607483A1,"ID   JB753850; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753850;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 155 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/155, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2334a0fec899ca64c4052fc9327c4983.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 6 C; 5 G; 3 T; 0 other;\r\n     ccttcagagg actccaagg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753849,EP2607483A1,"ID   JB753849; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753849;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 154 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/154, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e449e7da8e6b4e57d71e5b4bc655e1af.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 6 C; 6 G; 3 T; 0 other;\r\n     gccttcagag gactccaagg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753848,EP2607483A1,"ID   JB753848; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753848;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 153 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/153, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 281c179cf0e8b41cd020c868b0073e7c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 5 C; 7 G; 6 T; 0 other;\r\n     gaacattcaa cgctgtcggt gagt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753847,EP2607483A1,"ID   JB753847; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753847;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 152 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/152, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 73e0b281855c8aa4503c09e1d25c6cd6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 4 C; 7 G; 7 T; 0 other;\r\n     tcaacgctgt cggtgagttt g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753846,EP2607483A1,"ID   JB753846; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753846;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 151 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/151, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f87a942631c638d73d7d9a7bc006e7af.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 4 C; 6 G; 5 T; 0 other;\r\n     caacgctgtc ggtgagtt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753845,EP2607483A1,"ID   JB753845; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753845;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 150 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/150, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3b0523cc9b4d03d422b0e7c1e1f0e5a4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 3 A; 4 C; 8 G; 7 T; 0 other;\r\n     tcaacgctgt cggtgagttt gg                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753844,EP2607483A1,"ID   JB753844; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753844;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 149 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/149, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; be575c6381807654705c631f17697834.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 5 A; 5 C; 7 G; 8 T; 0 other;\r\n     acattcaacg ctgtcggtga gtttg                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753843,EP2607483A1,"ID   JB753843; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753843;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 148 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/148, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 602d3847731a8719e817dc4226728c55.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 5 G; 5 T; 0 other;\r\n     cattcaacgc tgtcggtga                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753842,EP2607483A1,"ID   JB753842; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753842;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 147 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/147, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a24273a29714717b1d6beec25dfa43e1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 4 C; 6 G; 7 T; 0 other;\r\n     ttcaacgctg tcggtgagtt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753841,EP2607483A1,"ID   JB753841; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753841;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 146 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/146, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3a1a904166888fa559685d5adabf3fd1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 4 C; 5 G; 5 T; 0 other;\r\n     attcaacgct gtcggtga                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753840,EP2607483A1,"ID   JB753840; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753840;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 145 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/145, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 02e406db30ae2a1ec8b5b6db73d02c83.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 4 C; 6 G; 5 T; 0 other;\r\n     tcaacgctgt cggtgagt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753839,EP2607483A1,"ID   JB753839; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753839;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 144 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/144, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b7b546809ab2ee5875de89334008cff6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 4 C; 6 G; 7 T; 0 other;\r\n     attcaacgct gtcggtgagt t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753838,EP2607483A1,"ID   JB753838; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753838;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 143 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/143, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9f557c3d330a39472b998b15ea27e09e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 4 C; 6 G; 5 T; 0 other;\r\n     ttcaacgctg tcggtgag                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753837,EP2607483A1,"ID   JB753837; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753837;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 142 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/142, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4aa97c8ecdd61e1251a3002b2ed82aac.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 4 C; 6 G; 6 T; 0 other;\r\n     ttcaacgctg tcggtgagt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753836,EP2607483A1,"ID   JB753836; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753836;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 141 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/141, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fdfe040fbb046a83a54ab9135bc47604.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 3 C; 6 G; 6 T; 0 other;\r\n     aacgctgtcg gtgagttt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753835,EP2607483A1,"ID   JB753835; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753835;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 140 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/140, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8942fd586ff97019387b7932a353318a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 4 C; 6 G; 6 T; 0 other;\r\n     caacgctgtc ggtgagttt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753834,EP2607483A1,"ID   JB753834; SV 1; linear; other RNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JB753834;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 139 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/139, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 48d8ed2824e35255ca96afc8247673e7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 6 A; 5 C; 8 G; 8 T; 0 other;\r\n     aacattcaac gctgtcggtg agtttgg                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753833,EP2607483A1,"ID   JB753833; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753833;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 138 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/138, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8c8aadf92fcc9415055ba62d32bd3859.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 6 A; 5 C; 7 G; 5 T; 0 other;\r\n     gaacattcaa cgctgtcggt gag                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753832,EP2607483A1,"ID   JB753832; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753832;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 137 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/137, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 683104516c8bb37a8371a40598cb5776.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 3 A; 4 C; 6 G; 6 T; 0 other;\r\n     tcaacgctgt cggtgagtt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753831,EP2607483A1,"ID   JB753831; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753831;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 136 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/136, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 099c85b0a925a8ced8a575fef7f96b35.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 5 C; 5 G; 5 T; 0 other;\r\n     cattcaacgc tgtcggtg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753830,EP2607483A1,"ID   JB753830; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753830;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 135 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/135, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; aaa2452aa284f8fe4b5242009d1c45f3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 3 A; 4 C; 6 G; 7 T; 0 other;\r\n     tcaacgctgt cggtgagttt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753829,EP2607483A1,"ID   JB753829; SV 1; linear; other RNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JB753829;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 134 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/134, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2accfda1f41c31d4b08e6360e65262cb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 7 A; 5 C; 8 G; 8 T; 0 other;\r\n     aacattcaac gctgtcggtg agtttgga                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753828,EP2607483A1,"ID   JB753828; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753828;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 133 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/133, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f99ff64bf6568a729aadab1acf58ee18.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 3 A; 4 C; 6 G; 8 T; 0 other;\r\n     ttcaacgctg tcggtgagtt t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753827,EP2607483A1,"ID   JB753827; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753827;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 132 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/132, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d942ba4757e4aefbffb4e1a4499094e8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 4 C; 6 G; 5 T; 0 other;\r\n     attcaacgct gtcggtgag                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753826,EP2607483A1,"ID   JB753826; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753826;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 131 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/131, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c5fce49accde2e08c8a0b79a14d183cb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 5 C; 6 G; 5 T; 0 other;\r\n     gaacattcaa cgctgtcggt g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753825,EP2607483A1,"ID   JB753825; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753825;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 130 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/130, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 062bae4166124a36cdbe238100d5ead9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 5 C; 6 G; 7 T; 0 other;\r\n     cattcaacgc tgtcggtgag tt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753824,EP2607483A1,"ID   JB753824; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753824;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 129 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/129, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0d0532a5c8f15db93ad7a90bdc155987.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 5 G; 5 T; 0 other;\r\n     gaacattcaa cgctgtcggt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753823,EP2607483A1,"ID   JB753823; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753823;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 128 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/128, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; eadca75530559eee8b43e5550621d9e9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 6 A; 5 C; 6 G; 5 T; 0 other;\r\n     gaacattcaa cgctgtcggt ga                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753822,EP2607483A1,"ID   JB753822; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753822;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 127 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/127, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 13dd4324fa42ce7d7d543acb91347dd7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 4 C; 6 G; 6 T; 0 other;\r\n     attcaacgct gtcggtgagt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753821,EP2607483A1,"ID   JB753821; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753821;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 126 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/126, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fa1090d8bdfdf969b8e05f84919a32da.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 5 C; 6 G; 5 T; 0 other;\r\n     cattcaacgc tgtcggtgag                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753820,EP2607483A1,"ID   JB753820; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753820;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 125 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/125, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 08669910a680d0c91e7e889b4d10d194.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 5 C; 6 G; 6 T; 0 other;\r\n     cattcaacgc tgtcggtgag t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753819,EP2607483A1,"ID   JB753819; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753819;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 124 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/124, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0a34b68a76dd2be51c321796c56373c5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 4 A; 4 C; 6 G; 8 T; 0 other;\r\n     attcaacgct gtcggtgagt tt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753818,EP2607483A1,"ID   JB753818; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753818;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 123 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/123, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2227d84632d5a0a28e9cd82ee44f00ce.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 5 C; 6 G; 8 T; 0 other;\r\n     cattcaacgc tgtcggtgag ttt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753817,EP2607483A1,"ID   JB753817; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753817;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 122 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/122, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f7c2a53e6a9970d7c6ddceab5f11cbee.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 4 A; 5 C; 4 G; 5 T; 0 other;\r\n     acattcaacg ctgtcggt                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753816,EP2607483A1,"ID   JB753816; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753816;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 121 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/121, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 54a8410c89fa948085df207ef77ca66a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 5 G; 5 T; 0 other;\r\n     acattcaacg ctgtcggtga                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753815,EP2607483A1,"ID   JB753815; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753815;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 120 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/120, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a6552dde177ce5e095339b5e997abed2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 5 C; 5 G; 5 T; 0 other;\r\n     acattcaacg ctgtcggtg                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753814,EP2607483A1,"ID   JB753814; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753814;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 119 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/119, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 712190a1e76e4577a28df0daae9c284e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 5 C; 6 G; 5 T; 0 other;\r\n     acattcaacg ctgtcggtga g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753813,EP2607483A1,"ID   JB753813; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753813;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 118 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/118, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c0ea1a0230068e2715ad742b564111a1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 5 A; 5 C; 6 G; 7 T; 0 other;\r\n     acattcaacg ctgtcggtga gtt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753812,EP2607483A1,"ID   JB753812; SV 1; linear; other RNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JB753812;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 117 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/117, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e8c8e62ddcf4a1910a712f1b4457fe0e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 5 A; 5 C; 4 G; 4 T; 0 other;\r\n     aacattcaac gctgtcgg                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753811,EP2607483A1,"ID   JB753811; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753811;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 116 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/116, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8381f590a37e2f4d17a6bd70cc40c5e7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 5 C; 6 G; 6 T; 0 other;\r\n     acattcaacg ctgtcggtga gt                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753810,EP2607483A1,"ID   JB753810; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753810;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 115 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/115, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 98b0cc1af0522c19b3a8c9cd76d7f858.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 5 A; 5 C; 6 G; 8 T; 0 other;\r\n     acattcaacg ctgtcggtga gttt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753809,EP2607483A1,"ID   JB753809; SV 1; linear; other RNA; PAT; SYN; 26 BP.\r\nXX\r\nAC   JB753809;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 114 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/114, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0a83350de5d9c406076db531ddd1ef06.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..26\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 26 BP; 6 A; 5 C; 7 G; 8 T; 0 other;\r\n     aacattcaac gctgtcggtg agtttg                                             26\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753808,EP2607483A1,"ID   JB753808; SV 1; linear; other RNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JB753808;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 113 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/113, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 70cd90551dc6c434444b1a534b74e0ba.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 5 A; 5 C; 4 G; 5 T; 0 other;\r\n     aacattcaac gctgtcggt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753807,EP2607483A1,"ID   JB753807; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753807;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 112 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/112, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 87ec70c7bf626c4469e77457a96b5821.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 6 A; 5 C; 6 G; 5 T; 0 other;\r\n     aacattcaac gctgtcggtg ag                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753806,EP2607483A1,"ID   JB753806; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753806;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 111 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/111, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; eab81ed2210b8142cd8423a7d7ef9ceb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 5 C; 5 G; 5 T; 0 other;\r\n     aacattcaac gctgtcggtg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753805,EP2607483A1,"ID   JB753805; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753805;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 110 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/110, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 76c628031e69fab4ebd646a3e0b3342c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 5 G; 5 T; 0 other;\r\n     aacattcaac gctgtcggtg                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753804,EP2607483A1,"ID   JB753804; SV 1; linear; other RNA; PAT; SYN; 24 BP.\r\nXX\r\nAC   JB753804;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 109 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/109, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 79edc85b5dbef9756593f59bb27c565d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..24\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 24 BP; 6 A; 5 C; 6 G; 7 T; 0 other;\r\n     aacattcaac gctgtcggtg agtt                                               24\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753803,EP2607483A1,"ID   JB753803; SV 1; linear; other RNA; PAT; SYN; 25 BP.\r\nXX\r\nAC   JB753803;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 108 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/108, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f079588810a62daefa9a0df7224df748.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..25\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""IsomiR sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 25 BP; 6 A; 5 C; 6 G; 8 T; 0 other;\r\n     aacattcaac gctgtcggtg agttt                                              25\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753802,EP2607483A1,"ID   JB753802; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753802;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 107 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/107, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 524e241f830e51a960ab809e7e6ddc68.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     tcaaact                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753801,EP2607483A1,"ID   JB753801; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753801;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 106 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/106, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 76cef8cd071e9acb2d926ae17af71f7d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 4 C; 2 G; 0 T; 0 other;\r\n     gccgcca                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753800,EP2607483A1,"ID   JB753800; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753800;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 105 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/105, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1ad728155d890b75c647f9fc14d5d65f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 4 C; 2 G; 1 T; 0 other;\r\n     tgccgcc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753799,EP2607483A1,"ID   JB753799; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753799;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 104 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/104, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a954846d2041bbd196a2d128f7176ee1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 3 C; 3 G; 1 T; 0 other;\r\n     gtgccgc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753798,EP2607483A1,"ID   JB753798; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753798;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 103 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/103, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f005ab9a5ff0a70265c9cde7c6699751.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     cctgaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753797,EP2607483A1,"ID   JB753797; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753797;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 102 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/102, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 58b4e4e0072aab896311ed0f19015d2c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     ccctgaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753796,EP2607483A1,"ID   JB753796; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753796;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 101 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/101, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ee7e05e1f5ad1907eb1228fd84f5b2d0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 1 G; 2 T; 0 other;\r\n     gactcct                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753795,EP2607483A1,"ID   JB753795; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753795;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 100 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/100, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 038616a489abeb93e0fe1d602ab002f7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 1 G; 2 T; 0 other;\r\n     tgactcc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753794,EP2607483A1,"ID   JB753794; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753794;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 99 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/99, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6e6ced88abf7fe0a0b7348822d1bdaef.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 1 C; 2 G; 1 T; 0 other;\r\n     gtgaaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753793,EP2607483A1,"ID   JB753793; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753793;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 98 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/98, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7756d7fdcde35ce28c2ce73edf5fa5d2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 1 C; 1 G; 4 T; 0 other;\r\n     tatctgt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753792,EP2607483A1,"ID   JB753792; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753792;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 97 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/97, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ecb7e63ee8b57ebd4acc2e0ab587bf2d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 1 C; 2 G; 1 T; 0 other;\r\n     gaaactg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753791,EP2607483A1,"ID   JB753791; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753791;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 96 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/96, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3cdc6a29952908bfab46cdbe2a623fdc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 1 C; 2 G; 3 T; 0 other;\r\n     atctgtg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753790,EP2607483A1,"ID   JB753790; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753790;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 95 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/95, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8ea1574af2432afab5333da7de997eeb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 0 C; 2 G; 3 T; 0 other;\r\n     atggtta                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753789,EP2607483A1,"ID   JB753789; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753789;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 94 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/94, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7b6cc522c932dc5ccad7f35fdbf5962e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 1 G; 3 T; 0 other;\r\n     tgctatc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753788,EP2607483A1,"ID   JB753788; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753788;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 93 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/93, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 11ba3ebbd95e710d2d58238f8795c220.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 1 G; 3 T; 0 other;\r\n     ctatctg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753787,EP2607483A1,"ID   JB753787; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753787;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 92 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/92, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c82eff2580b9bb3b867f00d81b190cb3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 1 C; 2 G; 2 T; 0 other;\r\n     ctgtgaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753786,EP2607483A1,"ID   JB753786; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753786;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 91 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/91, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0fe29abc399ab5c50479923ee70987db.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 1 C; 1 G; 2 T; 0 other;\r\n     tgaaact                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753785,EP2607483A1,"ID   JB753785; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753785;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 90 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/90, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1e2fda5ccb87a866cd8ed851b702e6fe.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 1 C; 2 G; 3 T; 0 other;\r\n     gtgctat                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753784,EP2607483A1,"ID   JB753784; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753784;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 89 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/89, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 72d0d62ddf08fa9e9e2087a9c64edce6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 0 C; 2 G; 2 T; 0 other;\r\n     tgtgaaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753783,EP2607483A1,"ID   JB753783; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753783;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 88 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/88, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6860d376d079ea959fe36116c975bdc2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 1 C; 3 G; 2 T; 0 other;\r\n     ggtgcta                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753782,EP2607483A1,"ID   JB753782; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753782;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 87 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/87, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; db6d912fbc22683215694b12239d85c5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 1 G; 3 T; 0 other;\r\n     gctatct                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753781,EP2607483A1,"ID   JB753781; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753781;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 86 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/86, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1207d0d18f1d98e03dd233ea9a25e336.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 1 C; 4 G; 2 T; 0 other;\r\n     gggtgct                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753780,EP2607483A1,"ID   JB753780; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753780;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 85 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/85, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 56c189ed1ee2fce1f8e7297ab1cd850c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 0 G; 2 T; 0 other;\r\n     tctcaca                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753779,EP2607483A1,"ID   JB753779; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753779;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 84 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/84, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9fe4c7a5694e3457475c47d03faa4cd5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 5 A; 1 C; 1 G; 0 T; 0 other;\r\n     acagaaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753778,EP2607483A1,"ID   JB753778; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753778;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 83 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/83, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c809ee51b64311a8e969521d25edd24f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 1 C; 1 G; 1 T; 0 other;\r\n     cagaaat                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753777,EP2607483A1,"ID   JB753777; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753777;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 82 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/82, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0a53da44cc32232cd61b0bad39797852.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 2 C; 1 G; 0 T; 0 other;\r\n     cacagaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753776,EP2607483A1,"ID   JB753776; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753776;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 81 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/81, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3f0a6a9845e60a1d5bf7b85360983701.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 2 C; 1 G; 0 T; 0 other;\r\n     acacaga                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753775,EP2607483A1,"ID   JB753775; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753775;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 80 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/80, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e39d582e9fc0b83e5c6b3274b3dd774a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 3 C; 0 G; 1 T; 0 other;\r\n     tcacaca                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753774,EP2607483A1,"ID   JB753774; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753774;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 79 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/79, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4fd533088d74841e7e75fdb6f3adf1ab.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 3 C; 1 G; 0 T; 0 other;\r\n     cacacag                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753773,EP2607483A1,"ID   JB753773; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753773;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 78 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/78, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5e83a82cd9f5d387ffa28cfcb23fa45f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 1 C; 3 G; 1 T; 0 other;\r\n     tgaaggc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753772,EP2607483A1,"ID   JB753772; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753772;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 77 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/77, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0cd86bea8a3df2f911274de8f0aaf724.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 1 C; 4 G; 0 T; 0 other;\r\n     gaggcag                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753771,EP2607483A1,"ID   JB753771; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753771;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 76 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/76, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 9ee398b93e9a053e19b218ceca77c6c2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 3 G; 0 T; 0 other;\r\n     cccgagg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753770,EP2607483A1,"ID   JB753770; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753770;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 75 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/75, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 35eb7b5e471849dcc935070be3c98058.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 1 G; 3 T; 0 other;\r\n     catctgt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753769,EP2607483A1,"ID   JB753769; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753769;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 74 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/74, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 634bbf47cb3a99a0a5a26928e3068034.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 1 G; 3 T; 0 other;\r\n     tcatctg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753768,EP2607483A1,"ID   JB753768; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753768;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 73 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/73, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c7af57ad4a2666914804248f40b6f793.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 1 G; 2 T; 0 other;\r\n     gcctcat                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753767,EP2607483A1,"ID   JB753767; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753767;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 72 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/72, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b66ebd5d85a4e7ba3b33d704ffe52149.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 0 G; 3 T; 0 other;\r\n     ctcatct                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753766,EP2607483A1,"ID   JB753766; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753766;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 71 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/71, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 449f8842fc26e1b032137ad7d2e1a6dd.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 4 C; 0 G; 2 T; 0 other;\r\n     cctcatc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753765,EP2607483A1,"ID   JB753765; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753765;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 70 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/70, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ed25b1b0a89035f0f11ed04c41567497.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 2 C; 3 G; 2 T; 0 other;\r\n     gtggtcc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753764,EP2607483A1,"ID   JB753764; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753764;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 69 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/69, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a8c2737aa5399c9c9487f4a87a7f3e31.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 0 C; 4 G; 2 T; 0 other;\r\n     aggtggt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753763,EP2607483A1,"ID   JB753763; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753763;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 68 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/68, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; fbfe18b319ba9f43a0e88c4943946731.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 2 C; 2 G; 3 T; 0 other;\r\n     gctgctt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753762,EP2607483A1,"ID   JB753762; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753762;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 67 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/67, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1a8343f2dd3a101c5cc9de9c247393b5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 1 C; 3 G; 3 T; 0 other;\r\n     tgcttgg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753761,EP2607483A1,"ID   JB753761; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753761;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 66 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/66, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 20c9dcb4021dc24cdb112fa746c32ec6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 2 C; 2 G; 3 T; 0 other;\r\n     ctgcttg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753760,EP2607483A1,"ID   JB753760; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753760;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 65 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/65, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; b29bc8582515a619df78ffbe4ded68e7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 2 C; 1 G; 2 T; 0 other;\r\n     gcacatt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753759,EP2607483A1,"ID   JB753759; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753759;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 64 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/64, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dc4094b30969d2fc597dde18a619e991.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 1 C; 3 G; 2 T; 0 other;\r\n     tatggcg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753758,EP2607483A1,"ID   JB753758; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753758;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 63 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/63, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 11159924676b849dded142ae46f3803f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     attacac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753757,EP2607483A1,"ID   JB753757; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753757;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 62 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/62, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 743ee1996a2c17374647916a84660980.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     cattaca                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753756,EP2607483A1,"ID   JB753756; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753756;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 61 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/61, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 74604bc9763fd25b4f1f41b043dd99d0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     cacatta                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753755,EP2607483A1,"ID   JB753755; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753755;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 60 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/60, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1e3420fdc108c755fd4d231db19bf2f9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 5 A; 2 C; 0 G; 0 T; 0 other;\r\n     aaaaacc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753754,EP2607483A1,"ID   JB753754; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753754;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 59 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/59, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; a4a647aa7d6b06fb57d5708e065e6eee.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 6 A; 1 C; 0 G; 0 T; 0 other;\r\n     aaaaaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753753,EP2607483A1,"ID   JB753753; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753753;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 58 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/58, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 085adeed00ff04887039998bbbb77ccb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 1 C; 4 G; 2 T; 0 other;\r\n     tggggtc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753752,EP2607483A1,"ID   JB753752; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753752;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 57 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/57, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d6b3ba1bbd213cbe7e4a2c75c7df0223.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 2 G; 1 T; 0 other;\r\n     ctgaccg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753751,EP2607483A1,"ID   JB753751; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753751;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 56 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/56, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 208493b9a68e0d96a0f00276367d58a0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     actgacc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753750,EP2607483A1,"ID   JB753750; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753750;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 55 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/55, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ff5ba8985be2ee4e4c6e4f16ae8efece.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     cactgac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753749,EP2607483A1,"ID   JB753749; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753749;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 54 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/54, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 23667eab3feedd8c4e693725e544611f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     accactg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753748,EP2607483A1,"ID   JB753748; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753748;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 53 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/53, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 6a99e3832d50b0a60b21e53a21d3da13.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 3 C; 0 G; 0 T; 0 other;\r\n     caaaacc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753747,EP2607483A1,"ID   JB753747; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753747;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 52 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/52, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 170fff8003c7c6c3ef8efa3bb3d37a71.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 2 C; 0 G; 1 T; 0 other;\r\n     tcaaaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753746,EP2607483A1,"ID   JB753746; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753746;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 51 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/51, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4a8fccb3ab5f1473578de3b965b24fcb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 2 G; 1 T; 0 other;\r\n     tcgaccg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753745,EP2607483A1,"ID   JB753745; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753745;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 50 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/50, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5f3520b18c5bb548adfe78a162286e2e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 4 A; 2 C; 0 G; 1 T; 0 other;\r\n     aaaccat                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753744,EP2607483A1,"ID   JB753744; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753744;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 49 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/49, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; aa4b1a29ffd0ead786fcc6bc670515e1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     catcgac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753743,EP2607483A1,"ID   JB753743; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753743;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 48 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/48, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 518c29f1d2d4816f7ee3c54dcb787790.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 3 C; 0 G; 1 T; 0 other;\r\n     aaccatc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753742,EP2607483A1,"ID   JB753742; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753742;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 47 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/47, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7c31f13ae23253a3e40e78512063cadb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     accatcg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753741,EP2607483A1,"ID   JB753741; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753741;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 46 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/46, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 95b3f83e3926e93c183350e6897b0b3c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 4 C; 2 G; 0 T; 0 other;\r\n     gccagcc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753740,EP2607483A1,"ID   JB753740; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753740;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 45 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/45, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2b33aa42d303df40e3bca1270ea6ccfc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 2 C; 1 G; 2 T; 0 other;\r\n     cttcaga                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753739,EP2607483A1,"ID   JB753739; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753739;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 44 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/44, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 51625d86affcdd7ba6efbf6e76e47d97.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 2 G; 2 T; 0 other;\r\n     acgctgt                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753738,EP2607483A1,"ID   JB753738; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753738;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 43 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/43, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 16a12f9a64060b5b4af8988a8ecddcb2.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 2 C; 2 G; 1 T; 0 other;\r\n     aacgctg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753737,EP2607483A1,"ID   JB753737; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753737;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 42 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/42, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 614c413c99f92447cd4fbd48cb1e56bb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 1 G; 2 T; 0 other;\r\n     ccttcag                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753736,EP2607483A1,"ID   JB753736; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753736;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 41 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/41, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ada2a92befd4ab791a4613eefe7f564a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     caacgct                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753735,EP2607483A1,"ID   JB753735; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753735;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 40 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/40, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2b0a7995d3a429bd17d9d6d0eafda941.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     tcaacgc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753734,EP2607483A1,"ID   JB753734; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753734;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 39 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/39, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8d86975812060d644f8a7c9700242ce4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     aacattc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753733,EP2607483A1,"ID   JB753733; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753733;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 38 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/38, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; dc381c4a0308755dd9c2829c796b8e4d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 2 C; 1 G; 2 T; 0 other;\r\n     ttcaacg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753732,EP2607483A1,"ID   JB753732; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753732;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 37 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/37, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 23c126785fa58064f52952bd65d67116.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     attcaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753731,EP2607483A1,"ID   JB753731; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753731;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 36 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/36, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; aefa4e51bb77f92de3aa30aaabccc8bc.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     cattcaa                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753730,EP2607483A1,"ID   JB753730; SV 1; linear; other DNA; PAT; SYN; 504 BP.\r\nXX\r\nAC   JB753730;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 35 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/35, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; f8a62b55ce42e8877c6ef657286b3c3f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..504\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 504 BP; 98 A; 124 C; 140 G; 142 T; 0 other;\r\n     ttggatctgg aggctatggg cgggggagtg ctttgaatat ctatacgtgg aaagccttgt        60\r\n     tttttacttt ttaagaaagg gtcgttaaat tcgtgctttg tagaccttca acagctcatc       120\r\n     aagggctact ctccacctcc ttgcttaaag gcctcttctg atgggtaagt gcttccactt       180\r\n     gcgatcgccg ccttgccgca tcccctcagc ctgtggcact caaactgtgg gggcactttc       240\r\n     tgctctctgg tgaaagtgcc gccatctttt gagtgttacc gcttgagaag actcaacctg       300\r\n     cggagaagat accattttga ttgggtgagg gggcgggtag caggatggcc ctagaccctg       360\r\n     cctatggccg cttcctcgtg atataaattt cttggccggg gctcttgcag atggagctgc       420\r\n     tcaccctgtg ggcctcaaat gtggagcact attctgatgt ccaagtggaa agtgctgcga       480\r\n     atttgagcgt caccggtgac gccc                                              504\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753729,EP2607483A1,"ID   JB753729; SV 1; linear; other DNA; PAT; SYN; 467 BP.\r\nXX\r\nAC   JB753729;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 34 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/34, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4fa1a718ee25b75b7a3582168af4a879.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..467\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequnece cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 467 BP; 96 A; 105 C; 159 G; 107 T; 0 other;\r\n     cggtttaggg tcacatggtt cttttatcca aattccagtg ggtacctacc tcctggaggt        60\r\n     gcaggtcgaa aggttctgtg tatttggtac taggacacac aggtaggtgt tgtcagtagt       120\r\n     gcagcctggt gctaggggca ggggtcccca gtgctcatgt tagtttcctt ttagagtcta       180\r\n     agtagaatgt taagcagaga cccaaaccct aggtctgctg actcctagtc cagggctcgt       240\r\n     gatggctggt gggccctgaa cgaggggtct ggaggcctgg gtttgaatat cgacagcctc       300\r\n     tctgacccac ttggttgcct cagggaggca ggtgtgcgga tgggggagag tggcccatgg       360\r\n     gccagaaaag cagtggtatg ggggccccaa gagaagccca gacccaaaag ggcaggagct       420\r\n     ggctgtgggg ctactcaggt ggctggaggc ctcctgcaga cacagtg                     467\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753728,EP2607483A1,"ID   JB753728; SV 1; linear; other DNA; PAT; SYN; 488 BP.\r\nXX\r\nAC   JB753728;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 33 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/33, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3f5e33b49cd10356b76859827797ae21.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..488\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 488 BP; 113 A; 137 C; 125 G; 112 T; 1 other;\r\n     cctgaagaga gactgacaca tcagaggtgt cyggtgactg aacaagctcc cagcttgcgc        60\r\n     ccatgtcata ttgtgtgcct ctcatagcct ggcacttcct gccattgcat ccttctctgc       120\r\n     agactaagat ggagttcctg aaccaagacc gcttgctggc caacctgtga aactgggctc       180\r\n     aaggtgaggg gtgctatctg tgattgaggg acatggttaa tggaattgtc tcacacagaa       240\r\n     atcgcacccg tcaccttggc ctacttatca ccaccccaaa cagaggaaca cgccttctcc       300\r\n     agccacagcc tatggaaggg ccttcagctg ctgtggcccc gaggtgtgca tactgtggaa       360\r\n     ggaacttcgg acgtgaactc ggatctggtt ccagtaccag ctgtgccagg agtgcccttg       420\r\n     ggcatgtcac tgacctaaga ctcagtttcg ccatctgtga aatggctgaa tcagactcac       480\r\n     ctcacagg                                                                488\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753727,EP2607483A1,"ID   JB753727; SV 1; linear; other DNA; PAT; SYN; 438 BP.\r\nXX\r\nAC   JB753727;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 32 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/32, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 5ad160835b39b63b7e2800471386131a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..438\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 438 BP; 106 A; 115 C; 112 G; 105 T; 0 other;\r\n     cgtccggcca gatctgcttc ttctgaaacc atggcaagag aaagacagac agacttggac        60\r\n     ctactgcagg gagggttaag tagcagcggg actcccatca agaagaagga atgtcttccg       120\r\n     gagcctcatc tgtctgttgg gctggaggca gggcctttgt gaaggcgggt ggtgctcaga       180\r\n     tcgcctctgg gcccttcctc cagccccgag gcggattcac catgaggctg atgcagcttc       240\r\n     agcttccagc ccttcacgct ccagggccct ttccaaggcc tagcaatgtg tccatgtgct       300\r\n     caggggtttt gtgaaatttg caaaaggaaa ttatttttgt actctttttt ttttaaaaca       360\r\n     aacaaacaaa caaaaaaaaa ccttccaagc tctgtaagct ttaggcgccc aagcccagct       420\r\n     ctgccctgct gtggcaag                                                     438\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753726,EP2607483A1,"ID   JB753726; SV 1; linear; other DNA; PAT; SYN; 483 BP.\r\nXX\r\nAC   JB753726;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 31 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/31, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 49b10010ad7c5ff902982ef2c8d43d58.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..483\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 483 BP; 87 A; 114 C; 145 G; 137 T; 0 other;\r\n     ttcctggtat ttgaagatgc ggttgaccat ggtgtgtacg ctttatttgt gacgtaggac        60\r\n     acatggtcta cttcttctca atatcacatc tcgccttgga agacttccag gaggtgatat       120\r\n     cagctttgcg gaagagccac tgtcctggtg tcagtacggc tgctgcttgg tacttggaga       180\r\n     gaggtggtcc gtggcgcgtt cgcttttttt atggcgcaca ttacacggtc gacctctttg       240\r\n     cagtatctaa tcccgccttg caagctttcc tggagctaac atcaactgcg ggggtggggg       300\r\n     ccactaggtc tgcgctcagt gcgacccagc ggggtttgtg atgtgtctgt cttgtgtgtg       360\r\n     acgataactc acgtgtggca gccctcttct cagcacactg ctctggcttg gcagcagggt       420\r\n     taacttgcgg acgaggagcg tggtgtcagc acgtgcctgg atacatgaga tggttgacca       480\r\n     gag                                                                     483\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753725,EP2607483A1,"ID   JB753725; SV 1; linear; other DNA; PAT; SYN; 486 BP.\r\nXX\r\nAC   JB753725;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 30 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/30, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 30e99fa1a058b227d641ac2060f47463.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..486\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""Sequence cloned in lentiviral vector""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 486 BP; 131 A; 105 C; 104 G; 146 T; 0 other;\r\n     ctgcacagtc tatcccacag ttcattagtt ctctgctgca cacaaattga ttttataatt        60\r\n     taaatactct cgacttgaaa cccagagagg aatgtaagag catccatcag cggtggtctc       120\r\n     actgctcact ggttcttggg atgtggatgg gagaatgaag aagggctatc aggccagcct       180\r\n     tcagaggact ccaaggaaca ttcaacgctg tcggtgagtt tgggatttga aaaaaccact       240\r\n     gaccgttgac tgtaccttgg ggtccttaca gacgacacta catttcctga agcaaaagag       300\r\n     caagctgtac cttcacatgt cacatgagtt caccagaaat ggtcctgcaa tcccccaaat       360\r\n     gtggtccagt gaattttatt cctactgctc actgttcctt gctttctgtt gtgtgtttta       420\r\n     ttattatttg tttgttttta caaaaaaagt gtttcatttc aacaaggtaa ggagcagtcc       480\r\n     atgatg                                                                  486\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753724,EP2607483A1,"ID   JB753724; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753724;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 29 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/29, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cfc281b6078c8950b9d5e05ab0c03de5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 4 A; 5 C; 6 G; 8 T; 0 other;\r\n     aagtgccgcc atcttttgag tgt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753723,EP2607483A1,"ID   JB753723; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753723;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 28 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/28, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cd29e8fa8a3c9bbf2e412ca235c4279c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 5 C; 6 G; 4 T; 0 other;\r\n     actcaaactg tgggggcact                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753722,EP2607483A1,"ID   JB753722; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753722;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 27 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/27, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2af407372f6f465999525ac77a5eaaa7.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 3 A; 8 C; 6 G; 5 T; 0 other;\r\n     gctgactcct agtccagggc tc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753721,EP2607483A1,"ID   JB753721; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753721;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 26 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/26, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 3b2fb6e89f83946932967fed5deadd29.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 7 A; 9 C; 3 G; 4 T; 0 other;\r\n     tctcacacag aaatcgcacc cgt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753720,EP2607483A1,"ID   JB753720; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753720;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 25 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/25, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 0f9419e28d0903f547586473cc029633.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 4 A; 2 C; 8 G; 7 T; 0 other;\r\n     aggggtgcta tctgtgattg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753719,EP2607483A1,"ID   JB753719; SV 1; linear; other RNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JB753719;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 24 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/24, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; af537781c12816b3fb57646dfc33229e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 1 A; 10 C; 4 G; 5 T; 0 other;\r\n     cctctgggcc cttcctccag                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753718,EP2607483A1,"ID   JB753718; SV 1; linear; other RNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JB753718;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 23 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/23, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 1b5597e55f3e09044d14ca4a84d35c50.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 8 C; 3 G; 5 T; 0 other;\r\n     cacattacac ggtcgacctc t                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753717,EP2607483A1,"ID   JB753717; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753717;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 22 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/22, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4fcfc35caa941cfbb12affcc4f0c418c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 1 A; 6 C; 10 G; 5 T; 0 other;\r\n     aggtggtccg tggcgcgttc gc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753716,EP2607483A1,"ID   JB753716; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753716;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 21 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/21, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 85ae8fb2506c03969ec2062bce03bfca.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 8 C; 4 G; 5 T; 0 other;\r\n     accactgacc gttgactgta cc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753715,EP2607483A1,"ID   JB753715; SV 1; linear; other RNA; PAT; SYN; 22 BP.\r\nXX\r\nAC   JB753715;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 20 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/20, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 32c12905db5bbc3611d79bd4257d65a0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..22\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 22 BP; 5 A; 7 C; 4 G; 6 T; 0 other;\r\n     accatcgacc gttgattgta cc                                                 22\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753714,EP2607483A1,"ID   JB753714; SV 1; linear; other RNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JB753714;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 19 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/19, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; c4ec7c94d55b2d6ced87884684c2bd3c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Mature sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 6 A; 5 C; 6 G; 6 T; 0 other;\r\n     aacattcaac gctgtcggtg agt                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753713,EP2607483A1,"ID   JB753713; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753713;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 18 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/18, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7c412f121743e104a2f6cd2c66809c91.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 2 C; 3 G; 1 T; 0 other;\r\n     agtgccg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753712,EP2607483A1,"ID   JB753712; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753712;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 17 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/17, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8cd94305b5ef9db2cd2ed1089329117a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 3 C; 0 G; 1 T; 0 other;\r\n     ctcaaac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753711,EP2607483A1,"ID   JB753711; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753711;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 16 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/16, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4ff5f789cc5ceb73adac268caec2c5d8.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 1 A; 3 C; 1 G; 2 T; 0 other;\r\n     ctgactc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753710,EP2607483A1,"ID   JB753710; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753710;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 15 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/15, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 726703e7cacd744ee5df7218062e909d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 4 C; 0 G; 1 T; 0 other;\r\n     ctcacac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753709,EP2607483A1,"ID   JB753709; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753709;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 14 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/14, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 506c88825a568317dbb4214ecadcf56f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 1 C; 5 G; 1 T; 0 other;\r\n     ggggtgc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753708,EP2607483A1,"ID   JB753708; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753708;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 13 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/13, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 97e446d1315c2772a18521c684b68199.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 2 C; 3 G; 2 T; 0 other;\r\n     ctctggg                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753707,EP2607483A1,"ID   JB753707; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753707;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 12 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/12, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 84ab550c9c884ea879491b4bcd7e9c62.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     acattac                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753706,EP2607483A1,"ID   JB753706; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753706;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 11 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/11, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; ec84b914d7a5416057d49f93e71e37c5.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 0 A; 1 C; 4 G; 2 T; 0 other;\r\n     ggtggtc                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753705,EP2607483A1,"ID   JB753705; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753705;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 10 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/10, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 16d177e1e399b62d717c8bc2b813bcb1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     ccactga                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753704,EP2607483A1,"ID   JB753704; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753704;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 9 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/9, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; e0c9ada930fd2d337cc19866b54000d3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 2 A; 3 C; 1 G; 1 T; 0 other;\r\n     ccatcga                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753703,EP2607483A1,"ID   JB753703; SV 1; linear; other RNA; PAT; SYN; 7 BP.\r\nXX\r\nAC   JB753703;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 8 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/8, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7d1c999893b97b57fb39fcc404874ac4.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..7\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Seed sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 7 BP; 3 A; 2 C; 0 G; 2 T; 0 other;\r\n     acattca                                                                   7\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753702,EP2607483A1,"ID   JB753702; SV 1; linear; other RNA; PAT; SYN; 67 BP.\r\nXX\r\nAC   JB753702;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 7 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/7, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 4a50ddd5a38a5dd6f511882bd26da98a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..67\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 67 BP; 11 A; 16 C; 19 G; 21 T; 0 other;\r\n     gtggcactca aactgtgggg gcactttctg ctctctggtg aaagtgccgc catcttttga        60\r\n     gtgttac                                                                  67\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753701,EP2607483A1,"ID   JB753701; SV 1; linear; other RNA; PAT; SYN; 98 BP.\r\nXX\r\nAC   JB753701;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 6 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/6, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 8427029ee6d0a7c76ee79d48385f6efe.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..98\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 98 BP; 18 A; 26 C; 33 G; 21 T; 0 other;\r\n     acccaaaccc taggtctgct gactcctagt ccagggctcg tgatggctgg tgggccctga        60\r\n     acgaggggtc tggaggcctg ggtttgaata tcgacagc                                98\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753700,EP2607483A1,"ID   JB753700; SV 1; linear; other RNA; PAT; SYN; 99 BP.\r\nXX\r\nAC   JB753700;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 5 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/5, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; cf50a2b5b10122fd208e93fc82da6502.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..99\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 99 BP; 25 A; 21 C; 28 G; 25 T; 0 other;\r\n     gaaactgggc tcaaggtgag gggtgctatc tgtgattgag ggacatggtt aatggaattg        60\r\n     tctcacacag aaatcgcacc cgtcaccttg gcctactta                               99\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753699,EP2607483A1,"ID   JB753699; SV 1; linear; other RNA; PAT; SYN; 95 BP.\r\nXX\r\nAC   JB753699;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 4 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/4, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 2cf77c0abc49c2a2dfe3c2fd7d1a4cb1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..95\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 95 BP; 11 A; 28 C; 33 G; 23 T; 0 other;\r\n     ctcatctgtc tgttgggctg gaggcagggc ctttgtgaag gcgggtggtg ctcagatcgc        60\r\n     ctctgggccc ttcctccagc cccgaggcgg attca                                   95\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753698,EP2607483A1,"ID   JB753698; SV 1; linear; other RNA; PAT; SYN; 86 BP.\r\nXX\r\nAC   JB753698;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 3 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/3, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 7cf6861fa59b0f071335a80c0996c797.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..86\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 86 BP; 15 A; 19 C; 24 G; 28 T; 0 other;\r\n     ttggtacttg gagagaggtg gtccgtggcg cgttcgcttt atttatggcg cacattacac        60\r\n     ggtcgacctc tttgcagtat ctaatc                                             86\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753697,EP2607483A1,"ID   JB753697; SV 1; linear; other RNA; PAT; SYN; 110 BP.\r\nXX\r\nAC   JB753697;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 2 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/2, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; d7ab2c9c786512e6fc476d1dea102601.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..110\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 110 BP; 29 A; 25 C; 30 G; 26 T; 0 other;\r\n     agaagggcta tcaggccagc cttcagagga ctccaaggaa cattcaacgc tgtcggtgag        60\r\n     tttgggattt gaaaaaacca ctgaccgttg actgtacctt ggggtcctta                  110\r\n//\r\n",rel_pat_syn_07_r122.dat
JB753696,EP2607483A1,"ID   JB753696; SV 1; linear; other RNA; PAT; SYN; 110 BP.\r\nXX\r\nAC   JB753696;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 1)\r\nXX\r\nDE   Sequence 1 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/1, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 940291148f1b307ca50e87be447c1cf9.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..110\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""Precursor sequence""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 110 BP; 30 A; 24 C; 22 G; 34 T; 0 other;\r\n     tgagttttga ggttgcttca gtgaacattc aacgctgtcg gtgagtttgg aattaaaatc        60\r\n     aaaaccatcg accgttgatt gtaccctatg gctaaccatc atctactcca                  110\r\n//\r\n",rel_pat_syn_07_r122.dat
JB754056,EP2607483A1,"ID   JB754056; SV 1; linear; protein; PRT; HUM; 6112 AA.\r\nXX\r\nAC   JB754056;\r\nXX\r\nDT   17-OCT-2013 (Rel. 118, Created)\r\nDT   17-OCT-2013 (Rel. 118, Last updated, Version 0)\r\nXX\r\nDE   Sequence 361 from Patent EP2607483.\r\nXX\r\nKW   .\r\nXX\r\nOS   Homo sapiens (human)\r\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\r\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;\r\nOC   Homo.\r\nXX\r\nRN   [1]\r\nRA   BRAKENHOFF R.H., VAN D.P., DE K.S., GOMMANS W.M.;\r\nRT   ""MiRNA for treating head and neck cancer"";\r\nRL   Patent number EP2607483-A1/361, 26-JUN-2013.\r\nRL   INTERNA TECHNOLOGIES B V [NL], VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS\r\nRL   WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG [NL].\r\nXX\r\nDR   MD5; 098916cee4787a0da01d4221cc1db618.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..6112\r\nFT                   /organism=""Homo sapiens""\r\nFT                   /mol_type=""protein""\r\nFT                   /db_xref=""taxon:9606""\r\nXX\r\nSQ   Sequence 6112 AA; 701264 MW; 28B3F676 CRC32;\r\n     MSLVLNDLLI CCRQLEHDRA TERKKEVEKF KRLIRDPETI KHLDRHSDSK QGKYLNWDAV        60\r\n     FRFLQKYIQK ETECLRIAKP NVSASTQASR QKKMQEISSL VKYFIKCANR RAPRLKCQEL       120\r\n     LNYIMDTVKD SSNGAIYGAD CSNILLKDIL SVRKYWCEIS QQQWLELFSV YFRLYLKPSQ       180\r\n     DVHRVLVARI IHAVTKGCCS QTDGLNSKFL DFFSKAIQCA RQEKSSSGLN HILAALTIFL       240\r\n     KTLAVNFRIR VCELGDEILP TLLYIWTQHR LNDSLKEVII ELFQLQIYIH HPKGAKTQEK       300\r\n     GAYESTKWRS ILYNLYDLLV NEISHIGSRG KYSSGFRNIA VKENLIELMA DICHQVFNED       360\r\n     TRSLEISQSY TTTQRESSDY SVPCKRKKIE LGWEVIKDHL QKSQNDFDLV PWLQIATQLI       420\r\n     SKYPASLPNC ELSPLLMILS QLLPQQRHGE RTPYVLRCLT EVALCQDKRS NLESSQKSDL       480\r\n     LKLWNKIWCI TFRGISSEQI QAENFGLLGA IIQGSLVEVD REFWKLFTGS ACRPSCPAVC       540\r\n     CLTLALTTSI VPGAVKMGIE QNMCEVNRSF SLKESIMKWL LFYQLEGDLE NSTEVPPILH       600\r\n     SNFPHLVLEK ILVSLTMKNC KAAMNFFQSV PECEHHQKDK EELSFSEVEE LFLQTTFDKM       660\r\n     DFLTIVRECG IEKHQSSIGF SVHQNLKESL DRCLLGLSEQ LLNNYSSEIT NSETLVRCSR       720\r\n     LLVGVLGCYC YMGVIAEEEA YKSELFQKAN SLMQCAGESI TLFKNKTNEE FRIGSLRNMM       780\r\n     QLCTRCLSNC TKKSPNKIAS GFFLRLLTSK LMNDIADICK SLASFIKKPF DRGEVESMED       840\r\n     DTNGNLMEVE DQSSMNLFND YPDSSVSDAN EPGESQSTIG AINPLAEEYL SKQDLLFLDM       900\r\n     LKFLCLCVTT AQTNTVSFRA ADIRRKLLML IDSSTLEPTK SLHLHMYLML LKELPGEEYP       960\r\n     LPMEDVLELL KPLSNVCSLY RRDQDVCKTI LNHVLHVVKN LGQSNMDSEN TRDAQGQFLT      1020\r\n     VIGAFWHLTK ERKYIFSVRM ALVNCLKTLL EADPYSKWAI LNVMGKDFPV NEVFTQFLAD      1080\r\n     NHHQVRMLAA ESINRLFQDT KGDSSRLLKA LPLKLQQTAF ENAYLKAQEG MREMSHSAEN      1140\r\n     PETLDEIYNR KSVLLTLIAV VLSCSPICEK QALFALCKSV KENGLEPHLV KKVLEKVSET      1200\r\n     FGYRRLEDFM ASHLDYLVLE WLNLQDTEYN LSSFPFILLN YTNIEDFYRS CYKVLIPHLV      1260\r\n     IRSHFDEVKS IANQIQEDWK SLLTDCFPKI LVNILPYFAY EGTRDSGMAQ QRETATKVYD      1320\r\n     MLKSENLLGK QIDHLFISNL PEIVVELLMT LHEPANSSAS QSTDLCDFSG DLDPAPNPPH      1380\r\n     FPSHVIKATF AYISNCHKTK LKSILEILSK SPDSYQKILL AICEQAAETN NVYKKHRILK      1440\r\n     IYHLFVSLLL KDIKSGLGGA WAFVLRDVIY TLIHYINQRP SCIMDVSLRS FSLCCDLLSQ      1500\r\n     VCQTAVTYCK DALENHLHVI VGTLIPLVYE QVEVQKQVLD LLKYLVIDNK DNENLYITIK      1560\r\n     LLDPFPDHVV FKDLRITQQK IKYSRGPFSL LEEINHFLSV SVYDALPLTR LEGLKDLRRQ      1620\r\n     LELHKDQMVD IMRASQDNPQ DGIMVKLVVN LLQLSKMAIN HTGEKEVLEA VGSCLGEVGP      1680\r\n     IDFSTIAIQH SKDASYTKAL KLFEDKELQW TFIMLTYLNN TLVEDCVKVR SAAVTCLKNI      1740\r\n     LATKTGHSFW EIYKMTTDPM LAYLQPFRTS RKKFLEVPRF DKENPFEGLD DINLWIPLSE      1800\r\n     NHDIWIKTLT CAFLDSGGTK CEILQLLKPM CEVKTDFCQT VLPYLIHDIL LQDTNESWRN      1860\r\n     LLSTHVQGFF TSCLRHFSQT SRSTTPANLD SESEHFFRCC LDKKSQRTML AVVDYMRRQK      1920\r\n     RPSSGTIFND AFWLDLNYLE VAKVAQSCAA HFTALLYAEI YADKKSMDDQ EKRSLAFEEG      1980\r\n     SQSTTISSLS EKSKEETGIS LQDLLLEIYR SIGEPDSLYG CGGGKMLQPI TRLRTYEHEA      2040\r\n     MWGKALVTYD LETAIPSSTR QAGIIQALQN LGLCHILSVY LKGLDYENKD WCPELEELHY      2100\r\n     QAAWRNMQWD HCTSVSKEVE GTSYHESLYN ALQSLRDREF STFYESLKYA RVKEVEEMCK      2160\r\n     RSLESVYSLY PTLSRLQAIG ELESIGELFS RSVTHRQLSE VYIKWQKHSQ LLKDSDFSFQ      2220\r\n     EPIMALRTVI LEILMEKEMD NSQRECIKDI LTKHLVELSI LARTFKNTQL PERAIFQIKQ      2280\r\n     YNSVSCGVSE WQLEEAQVFW AKKEQSLALS ILKQMIKKLD ASCAANNPSL KLTYTECLRV      2340\r\n     CGNWLAETCL ENPAVIMQTY LEKAVEVAGN YDGESSDELR NGKMKAFLSL ARFSDTQYQR      2400\r\n     IENYMKSSEF ENKQALLKRA KEEVGLLREH KIQTNRYTVK VQRELELDEL ALRALKEDRK      2460\r\n     RFLCKAVENY INCLLSGEEH DMWVFRLCSL WLENSGVSEV NGMMKRDGMK IPTYKFLPLM      2520\r\n     YQLAARMGTK MMGGLGFHEV LNNLISRISM DHPHHTLFII LALANANRDE FLTKPEVARR      2580\r\n     SRITKNVPKQ SSQLDEDRTE AANRIICTIR SRRPQMVRSV EALCDAYIIL ANLDATQWKT      2640\r\n     QRKGINIPAD QPITKLKNLE DVVVPTMEIK VDHTGEYGNL VTIQSFKAEF RLAGGVNLPK      2700\r\n     IIDCVGSDGK ERRQLVKGRD DLRQDAVMQQ VFQMCNTLLQ RNTETRKRKL TICTYKVVPL      2760\r\n     SQRSGVLEWC TGTVPIGEFL VNNEDGAHKR YRPNDFSAFQ CQKKMMEVQK KSFEEKYEVF      2820\r\n     MDVCQNFQPV FRYFCMEKFL DPAIWFEKRL AYTRSVATSS IVGYILGLGD RHVQNILINE      2880\r\n     QSAELVHIDL GVAFEQGKIL PTPETVPFRL TRDIVDGMGI TGVEGVFRRC CEKTMEVMRN      2940\r\n     SQETLLTIVE VLLYDPLFDW TMNPLKALYL QQRPEDETEL HPTLNADDQE CKRNLSDIDQ      3000\r\n     SFDKVAERVL MRLQEKLKGV EEGTVLSVGG QVNLLIQQAI DPKNLSRLFP GWKAWVMSLV      3060\r\n     LNDLLICCRQ LEHDRATERK KEVEKFKRLI RDPETIKHLD RHSDSKQGKY LNWDAVFRFL      3120\r\n     QKYIQKETEC LRIAKPNVSA STQASRQKKM QEISSLVKYF IKCANRRAPR LKCQELLNYI      3180\r\n     MDTVKDSSNG AIYGADCSNI LLKDILSVRK YWCEISQQQW LELFSVYFRL YLKPSQDVHR      3240\r\n     VLVARIIHAV TKGCCSQTDG LNSKFLDFFS KAIQCARQEK SSSGLNHILA ALTIFLKTLA      3300\r\n     VNFRIRVCEL GDEILPTLLY IWTQHRLNDS LKEVIIELFQ LQIYIHHPKG AKTQEKGAYE      3360\r\n     STKWRSILYN LYDLLVNEIS HIGSRGKYSS GFRNIAVKEN LIELMADICH QVFNEDTRSL      3420\r\n     EISQSYTTTQ RESSDYSVPC KRKKIELGWE VIKDHLQKSQ NDFDLVPWLQ IATQLISKYP      3480\r\n     ASLPNCELSP LLMILSQLLP QQRHGERTPY VLRCLTEVAL CQDKRSNLES SQKSDLLKLW      3540\r\n     NKIWCITFRG ISSEQIQAEN FGLLGAIIQG SLVEVDREFW KLFTGSACRP SCPAVCCLTL      3600\r\n     ALTTSIVPGA VKMGIEQNMC EVNRSFSLKE SIMKWLLFYQ LEGDLENSTE VPPILHSNFP      3660\r\n     HLVLEKILVS LTMKNCKAAM NFFQSVPECE HHQKDKEELS FSEVEELFLQ TTFDKMDFLT      3720\r\n     IVRECGIEKH QSSIGFSVHQ NLKESLDRCL LGLSEQLLNN YSSEITNSET LVRCSRLLVG      3780\r\n     VLGCYCYMGV IAEEEAYKSE LFQKANSLMQ CAGESITLFK NKTNEEFRIG SLRNMMQLCT      3840\r\n     RCLSNCTKKS PNKIASGFFL RLLTSKLMND IADICKSLAS FIKKPFDRGE VESMEDDTNG      3900\r\n     NLMEVEDQSS MNLFNDYPDS SVSDANEPGE SQSTIGAINP LAEEYLSKQD LLFLDMLKFL      3960\r\n     CLCVTTAQTN TVSFRAADIR RKLLMLIDSS TLEPTKSLHL HMYLMLLKEL PGEEYPLPME      4020\r\n     DVLELLKPLS NVCSLYRRDQ DVCKTILNHV LHVVKNLGQS NMDSENTRDA QGQFLTVIGA      4080\r\n     FWHLTKERKY IFSVRMALVN CLKTLLEADP YSKWAILNVM GKDFPVNEVF TQFLADNHHQ      4140\r\n     VRMLAAESIN RLFQDTKGDS SRLLKALPLK LQQTAFENAY LKAQEGMREM SHSAENPETL      4200\r\n     DEIYNRKSVL LTLIAVVLSC SPICEKQALF ALCKSVKENG LEPHLVKKVL EKVSETFGYR      4260\r\n     RLEDFMASHL DYLVLEWLNL QDTEYNLSSF PFILLNYTNI EDFYRSCYKV LIPHLVIRSH      4320\r\n     FDEVKSIANQ IQEDWKSLLT DCFPKILVNI LPYFAYEGTR DSGMAQQRET ATKVYDMLKS      4380\r\n     ENLLGKQIDH LFISNLPEIV VELLMTLHEP ANSSASQSTD LCDFSGDLDP APNPPHFPSH      4440\r\n     VIKATFAYIS NCHKTKLKSI LEILSKSPDS YQKILLAICE QAAETNNVYK KHRILKIYHL      4500\r\n     FVSLLLKDIK SGLGGAWAFV LRDVIYTLIH YINQRPSCIM DVSLRSFSLC CDLLSQVCQT      4560\r\n     AVTYCKDALE NHLHVIVGTL IPLVYEQVEV QKQVLDLLKY LVIDNKDNEN LYITIKLLDP      4620\r\n     FPDHVVFKDL RITQQKIKYS RGPFSLLEEI NHFLSVSVYD ALPLTRLEGL KDLRRQLELH      4680\r\n     KDQMVDIMRA SQDNPQDGIM VKLVVNLLQL SKMAINHTGE KEVLEAVGSC LGEVGPIDFS      4740\r\n     TIAIQHSKDA SYTKALKLFE DKELQWTFIM LTYLNNTLVE DCVKVRSAAV TCLKNILATK      4800\r\n     TGHSFWEIYK MTTDPMLAYL QPFRTSRKKF LEVPRFDKEN PFEGLDDINL WIPLSENHDI      4860\r\n     WIKTLTCAFL DSGGTKCEIL QLLKPMCEVK TDFCQTVLPY LIHDILLQDT NESWRNLLST      4920\r\n     HVQGFFTSCL RHFSQTSRST TPANLDSESE HFFRCCLDKK SQRTMLAVVD YMRRQKRPSS      4980\r\n     GTIFNDAFWL DLNYLEVAKV AQSCAAHFTA LLYAEIYADK KSMDDQEKRS LAFEEGSQST      5040\r\n     TISSLSEKSK EETGISLQDL LLEIYRSIGE PDSLYGCGGG KMLQPITRLR TYEHEAMWGK      5100\r\n     ALVTYDLETA IPSSTRQAGI IQALQNLGLC HILSVYLKGL DYENKDWCPE LEELHYQAAW      5160\r\n     RNMQWDHCTS VSKEVEGTSY HESLYNALQS LRDREFSTFY ESLKYARVKE VEEMCKRSLE      5220\r\n     SVYSLYPTLS RLQAIGELES IGELFSRSVT HRQLSEVYIK WQKHSQLLKD SDFSFQEPIM      5280\r\n     ALRTVILEIL MEKEMDNSQR ECIKDILTKH LVELSILART FKNTQLPERA IFQIKQYNSV      5340\r\n     SCGVSEWQLE EAQVFWAKKE QSLALSILKQ MIKKLDASCA ANNPSLKLTY TECLRVCGNW      5400\r\n     LAETCLENPA VIMQTYLEKA VEVAGNYDGE SSDELRNGKM KAFLSLARFS DTQYQRIENY      5460\r\n     MKSSEFENKQ ALLKRAKEEV GLLREHKIQT NRYTVKVQRE LELDELALRA LKEDRKRFLC      5520\r\n     KAVENYINCL LSGEEHDMWV FRLCSLWLEN SGVSEVNGMM KRDGMKIPTY KFLPLMYQLA      5580\r\n     ARMGTKMMGG LGFHEVLNNL ISRISMDHPH HTLFIILALA NANRDEFLTK PEVARRSRIT      5640\r\n     KNVPKQSSQL DEDRTEAANR IICTIRSRRP QMVRSVEALC DAYIILANLD ATQWKTQRKG      5700\r\n     INIPADQPIT KLKNLEDVVV PTMEIKVDHT GEYGNLVTIQ SFKAEFRLAG GVNLPKIIDC      5760\r\n     VGSDGKERRQ LVKGRDDLRQ DAVMQQVFQM CNTLLQRNTE TRKRKLTICT YKVVPLSQRS      5820\r\n     GVLEWCTGTV PIGEFLVNNE DGAHKRYRPN DFSAFQCQKK MMEVQKKSFE EKYEVFMDVC      5880\r\n     QNFQPVFRYF CMEKFLDPAI WFEKRLAYTR SVATSSIVGY ILGLGDRHVQ NILINEQSAE      5940\r\n     LVHIDLGVAF EQGKILPTPE TVPFRLTRDI VDGMGITGVE GVFRRCCEKT MEVMRNSQET      6000\r\n     LLTIVEVLLY DPLFDWTMNP LKALYLQQRP EDETELHPTL NADDQECKRN LSDIDQSFDK      6060\r\n     VAERVLMRLQ EKLKGVEEGT VLSVGGQVNL LIQQAIDPKN LSRLFPGWKA WV              6112\r\n//\r\n",epo_prt.dat
JC011835,EP2639585A1,"ID   JC011835; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011835;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 31 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/31, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 10bbb8fbd4174736a45ad76de8a5479c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 6 A; 3 C; 8 G; 3 T; 0 other;\r\n     atgggagcca aggtaggact                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011834,EP2639585A1,"ID   JC011834; SV 1; linear; other DNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JC011834;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 30 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/30, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 8700ef46def8bc3542ca2a31e83b0335.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 4 A; 4 C; 5 G; 6 T; 0 other;\r\n     aaattgtgcc ctgcgagtt                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011833,EP2639585A1,"ID   JC011833; SV 1; linear; other DNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JC011833;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 29 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/29, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 0dbb69c137b43e363c3b5969fe0c7f0f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 5 C; 5 G; 5 T; 0 other;\r\n     ttcttgctgc ccaaggag                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011832,EP2639585A1,"ID   JC011832; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011832;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 28 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/28, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 471ef7afeaebaca32129670c0ece3e6c.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 3 C; 7 G; 3 T; 0 other;\r\n     tccaggtgaa gcagaaaggt                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011831,EP2639585A1,"ID   JC011831; SV 1; linear; other DNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JC011831;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 27 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/27, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 641d821bcaf2ad1d747ab87e24ca0cbb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 10 A; 4 C; 5 G; 8 T; 0 other;\r\n     cccttaatga atttatagag gaacgta                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011830,EP2639585A1,"ID   JC011830; SV 1; linear; other DNA; PAT; SYN; 18 BP.\r\nXX\r\nAC   JC011830;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 26 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/26, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 21234da5fa26f5da7c9e3e3d2e6619ae.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..18\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 18 BP; 3 A; 5 C; 6 G; 4 T; 0 other;\r\n     gctgtgcgcc taggacat                                                      18\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011829,EP2639585A1,"ID   JC011829; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011829;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 25 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/25, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 251782731df7280e5f64975bff5be313.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 7 C; 4 G; 5 T; 0 other;\r\n     ttagcccatg tcaggacctc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011828,EP2639585A1,"ID   JC011828; SV 1; linear; other DNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JC011828;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 24 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/24, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 53ff8264ac302aef32578f04dd4e9fda.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 6 A; 7 C; 2 G; 4 T; 0 other;\r\n     ccgattgcat cacaaccat                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011827,EP2639585A1,"ID   JC011827; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011827;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 23 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/23, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; bad0b1c0f96bb4a3d97776ad537f9079.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 5 A; 7 C; 4 G; 4 T; 0 other;\r\n     gccatcaagc tcaggctcta                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011826,EP2639585A1,"ID   JC011826; SV 1; linear; other DNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JC011826;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 22 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/22, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 103cad66056ba7c83f1daa21f48310e1.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 6 C; 4 G; 5 T; 0 other;\r\n     catcaacagc tttgaccagt g                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011825,EP2639585A1,"ID   JC011825; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011825;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 21 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/21, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 12663099c11d2fc9a8f2266c1255e03a.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 7 A; 4 C; 6 G; 3 T; 0 other;\r\n     gaagggcggt aaccatcata                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011824,EP2639585A1,"ID   JC011824; SV 1; linear; other DNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JC011824;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 20 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/20, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; f6c332a55a508ad34814179969b8f77b.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 6 A; 2 C; 8 G; 5 T; 0 other;\r\n     gctagaggct tgatgaatgg a                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011823,EP2639585A1,"ID   JC011823; SV 1; linear; other DNA; PAT; SYN; 20 BP.\r\nXX\r\nAC   JC011823;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 19 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/19, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 62546e20629716287738d0be651b39fb.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..20\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 20 BP; 4 A; 3 C; 8 G; 5 T; 0 other;\r\n     caggggttgt gttgaagacc                                                    20\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011822,EP2639585A1,"ID   JC011822; SV 1; linear; other DNA; PAT; SYN; 23 BP.\r\nXX\r\nAC   JC011822;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 18 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/18, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 3a57204e3c797b350c8f614e992dc85d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..23\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 23 BP; 8 A; 3 C; 7 G; 5 T; 0 other;\r\n     tcaagactat ctgaagggaa tgg                                                23\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011821,EP2639585A1,"ID   JC011821; SV 1; linear; other DNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JC011821;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 17 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/17, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 3c28967a69ab135c565ee6786e583b47.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 7 A; 8 C; 2 G; 2 T; 0 other;\r\n     gcccaatacg accaaatcc                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011820,EP2639585A1,"ID   JC011820; SV 1; linear; other DNA; PAT; SYN; 19 BP.\r\nXX\r\nAC   JC011820;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 16 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/16, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 9959309a425e671b21219c5c9ac698a0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..19\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 19 BP; 6 A; 8 C; 3 G; 2 T; 0 other;\r\n     agccacatcg ctcagacac                                                     19\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011819,EP2639585A1,"ID   JC011819; SV 1; linear; other DNA; PAT; SYN; 21 BP.\r\nXX\r\nAC   JC011819;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 15 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/15, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 29159009a32074bbb5d524b1261bb486.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..21\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 21 BP; 5 A; 5 C; 5 G; 6 T; 0 other;\r\n     tggaacgctt cacgaatttg c                                                  21\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011818,EP2639585A1,"ID   JC011818; SV 1; linear; other DNA; PAT; SYN; 17 BP.\r\nXX\r\nAC   JC011818;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 14 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/14, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 82c5476724f1b446ac29c5b062cc6c3f.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..17\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 17 BP; 1 A; 6 C; 6 G; 4 T; 0 other;\r\n     gtgctcgctt cggcagc                                                       17\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011817,EP2639585A1,"ID   JC011817; SV 1; linear; other DNA; PAT; SYN; 45 BP.\r\nXX\r\nAC   JC011817;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 13 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/13, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 9fb16e50f6a008d35dc5d9dbb1af9068.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..45\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 45 BP; 14 A; 13 C; 10 G; 8 T; 0 other;\r\n     ataagaatgc ggccgcctaa atattgctga gagcatccac cccag                        45\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011816,EP2639585A1,"ID   JC011816; SV 1; linear; other DNA; PAT; SYN; 27 BP.\r\nXX\r\nAC   JC011816;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 12 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/12, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; dda30f27adc35d5a9cfdbb8d32de3f70.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..27\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 27 BP; 6 A; 7 C; 6 G; 8 T; 0 other;\r\n     atgtcgcttt ctaacaagct gacgctg                                            27\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011815,EP2639585A1,"ID   JC011815; SV 1; linear; other DNA; PAT; SYN; 26 BP.\r\nXX\r\nAC   JC011815;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 11 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/11, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 91f21ebdcf13617a02c08355be900e15.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..26\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""primer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 26 BP; 6 A; 9 C; 3 G; 8 T; 0 other;\r\n     ctattgatgc caacagcctt tccatc                                             26\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011814,EP2639585A1,"ID   JC011814; SV 1; linear; other DNA; PAT; SYN; 49 BP.\r\nXX\r\nAC   JC011814;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 10 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/10, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 5d097f6ad07758a15c3133ee88c3e0be.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..49\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""perimer""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 49 BP; 10 A; 15 C; 17 G; 7 T; 0 other;\r\n     ttcagtcgac atggcggccg ccagcggcta cacggacctg cgtgagaag                    49\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011813,EP2639585A1,"ID   JC011813; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011813;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 9 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/9, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 9460cc840ce25a13e6e2d9bef5012755.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 1 A; 9 C; 6 G; 12 T; 0 other;\r\n     tctctgctcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011812,EP2639585A1,"ID   JC011812; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011812;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 8 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/8, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; e966267e8e6e7c2fed78f06433b80b93.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 8 C; 6 G; 12 T; 0 other;\r\n     tctcgtatcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011811,EP2639585A1,"ID   JC011811; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011811;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 7 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/7, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 2e019ba89fc7ccda16a5ca9ea79b121e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 9 C; 5 G; 12 T; 0 other;\r\n     tctccattcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011810,EP2639585A1,"ID   JC011810; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011810;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 6 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/6, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 6952fe4d0225f5ddede2c03e04fbf9ef.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 9 C; 6 G; 11 T; 0 other;\r\n     tctcacgtcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011809,EP2639585A1,"ID   JC011809; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011809;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 5 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/5, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 5384ca6271e63f5c370739bc1df6daea.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 7 C; 5 G; 14 T; 0 other;\r\n     tcttttatcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011808,EP2639585A1,"ID   JC011808; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011808;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 4 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/4, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 65d8ee3bb49aa0b0421000f7606f7c41.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 7 C; 8 G; 11 T; 0 other;\r\n     tctgggatcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011807,EP2639585A1,"ID   JC011807; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011807;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 3 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/3, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 84a5dfd12fdf08814369788ca8c39455.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""3' barcoded adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 2 A; 10 C; 5 G; 11 T; 0 other;\r\n     tctcccatcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011806,EP2639585A1,"ID   JC011806; SV 1; linear; other DNA; PAT; SYN; 28 BP.\r\nXX\r\nAC   JC011806;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 2 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/2, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 7e9cf829a72576e933cf8dc96215cd4d.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..28\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other DNA""\r\nFT                   /note=""3' barcoded adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 28 BP; 5 A; 7 C; 5 G; 11 T; 0 other;\r\n     tctaaaatcg tatgccgtct tctgcttg                                           28\r\n//\r\n",rel_pat_syn_07_r122.dat
JC011805,EP2639585A1,"ID   JC011805; SV 1; linear; other RNA; PAT; SYN; 52 BP.\r\nXX\r\nAC   JC011805;\r\nXX\r\nDT   24-JAN-2014 (Rel. 119, Created)\r\nDT   24-JAN-2014 (Rel. 119, Last updated, Version 1)\r\nXX\r\nDE   Sequence 1 from Patent EP2639585.\r\nXX\r\nKW   .\r\nXX\r\nOS   synthetic construct\r\nOC   other sequences; artificial sequences.\r\nXX\r\nRN   [1]\r\nRA   MUNSCHAUER M., LANDTHALER M.;\r\nRT   ""Method for identification of the sequence of poly(A)+RNA that physically\r\nRT   interacts with protein"";\r\nRL   Patent number EP2639585-A1/1, 18-SEP-2013.\r\nRL   MAX DELBRUECK CENTRUM [DE].\r\nXX\r\nDR   MD5; 5fc32c47a377ae49b0e5a679f8ea5df0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..52\r\nFT                   /organism=""synthetic construct""\r\nFT                   /mol_type=""other RNA""\r\nFT                   /note=""cloning adapter""\r\nFT                   /db_xref=""taxon:32630""\r\nXX\r\nSQ   Sequence 52 BP; 6 A; 7 C; 6 G; 7 T; 26 other;\r\n     rgrtrtrcra rgrargrtrt rcrtrarcra rgrtrcrcrg rarcrgrart rc                52\r\n//\r\n",rel_pat_syn_07_r122.dat
ABL32763,US7135460A,"ID   ABL32763       STANDARD;       PRT;   165 AA.\r\nXX\r\nAC   ABL32763;\r\nXX\r\nSV   ABL32763.1 \r\nXX\r\nDT   06-DEC-2006\r\nXX\r\nDE   Sequence 1 from patent US 7135460.\r\nXX\r\nOS   Unknown\r\nXX\r\nRN   [1]\r\nRP   [1-165]\r\nRA   Kinstler,O., Gegg,C., Freeman,A. and Boone,T.;\r\nRT   ""Chemically modified novel erythropoietin stimulating protein\r\nRT   compositions and methods"";\r\nRL   Patent number US7135460-A/1 14-NOV-2006;\r\nRL   Amgen Inc.; Thousand Oaks, CA;\r\nRL   US;\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFT   source          1..165\r\nXX\r\nSQ   SEQUENCE   165 AA;  F8503133 CRC32;\r\n     APPRLICDSR VLERYLLEAK EAENITTGCN ETCSLNENIT VPDTKVNFYA WKRMEVGQQA        60\r\n     VEVWQGLALL SEAVLRGQAL LVNSSQVNET LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS       120\r\n     PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD                       165\r\n//\r\n",uspto_prt.dat
EA028895,US7138514A,"ID   EA028895; SV 1; linear; genomic DNA; PAT; UNC; 690 BP.\r\nXX\r\nAC   EA028895;\r\nXX\r\nDT   07-DEC-2006 (Rel. 90, Created)\r\nDT   07-DEC-2006 (Rel. 90, Last updated, Version 1)\r\nXX\r\nDE   Sequence 7 from patent US 7138514.\r\nXX\r\nKW   .\r\nXX\r\nOS   unidentified\r\nOC   unclassified sequences.\r\nXX\r\nRN   [1]\r\nRP   1-690\r\nRA   Coleman P.F., Mushahwar I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/7, 21-NOV-2006.\r\nRL   Abbott Laboratories;\r\nRL   Abbott Park, IL;\r\nRL   US;.\r\nXX\r\nDR   MD5; dfa27114b231b4a8c03489f8d9f0f51e.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..690\r\nFT                   /organism=""unidentified""\r\nFT                   /mol_type=""genomic DNA""\r\nFT                   /db_xref=""taxon:32644""\r\nXX\r\nSQ   Sequence 690 BP; 132 A; 190 C; 147 G; 221 T; 0 other;\r\n     gcgctgaaca tggagaacat cacatcagga ttcctaggac ccctgctcgt gttacaggcg        60\r\n     gggtttttct tgttgacaag aatcctcaca ataccgcaga gtctagactc gtggtggact       120\r\n     tctctcaatt ttctaggggg aactaccgtg tgtcttggcc aaaattcgca gtccccaacc       180\r\n     tccaatcact caccaacctc ctgtcctcca acttgtcctg gttatcgctg gatgtgtctg       240\r\n     cggcgtttta tcatcttcct cttcatcctg ctgctatgcc tcatcttctt gttggttctt       300\r\n     ctggactatc aaggtatgtt gcccgtttgt cctctaattc caggatcatc aaccaccagc       360\r\n     acgggaccct gcaggacctg cacgactcct gctcaaggaa cctctatgta tccctcctgt       420\r\n     tgctgtacaa aaccttcgga tggaaactgc acctgtattc ccatcccatc atcctgggct       480\r\n     ttcggaaaat tcctatggga gtgggcctca gcccgtttct cttggctcag tttactagtg       540\r\n     ccatttgttc agtggttcgt agggctttcc cccactgttt ggctttcagt tatatggatg       600\r\n     atgtggtatt gggggccaag tctgtacagc atcttgagtc cctttttacc gctgttacca       660\r\n     attttctttt gtctttgggt atacatttaa                                        690\r\n//\r\n",rel_pat_unc_02_r122.dat
EA028894,US7138514A,"ID   EA028894; SV 1; linear; genomic DNA; PAT; UNC; 690 BP.\r\nXX\r\nAC   EA028894;\r\nXX\r\nDT   07-DEC-2006 (Rel. 90, Created)\r\nDT   07-DEC-2006 (Rel. 90, Last updated, Version 1)\r\nXX\r\nDE   Sequence 6 from patent US 7138514.\r\nXX\r\nKW   .\r\nXX\r\nOS   unidentified\r\nOC   unclassified sequences.\r\nXX\r\nRN   [1]\r\nRP   1-690\r\nRA   Coleman P.F., Mushahwar I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/6, 21-NOV-2006.\r\nRL   Abbott Laboratories;\r\nRL   Abbott Park, IL;\r\nRL   US;.\r\nXX\r\nDR   MD5; fa4cb2b8f948a10810038a81f0c227d3.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..690\r\nFT                   /organism=""unidentified""\r\nFT                   /mol_type=""genomic DNA""\r\nFT                   /db_xref=""taxon:32644""\r\nXX\r\nSQ   Sequence 690 BP; 132 A; 192 C; 146 G; 220 T; 0 other;\r\n     gcgcggaaca tggagaacat cacatcagga ttcctaggac ccctgctcgt gttacaggcg        60\r\n     gggtttttct tgttgacaag aatcctcaca ataccgcaga gtctagactc gtggtggact       120\r\n     tctctcaatt ttctaggggg aactaccgtg tgtcttggcc aaaattcgca gtccccaacc       180\r\n     tccaatcact caccaacctc ctgtcctcca acttgtcctg gttatcgctg gatgtgtctg       240\r\n     cggcgtttta tcatcttcct cttcatcctg ctgctatgcc tcatcttctt gttggttctt       300\r\n     ctggactatc aaggtatgtt gcccgtttgt cctctaattc caggatcttc aaccaccagc       360\r\n     acgggaccat gcagagcctg cacgactcct gctcaaggaa cctctatgta tccctcctgt       420\r\n     tgctgtacaa aaccttcgga tggaaactgc acctgtattc ccatcccatc atcctgggct       480\r\n     ttcggaaaat tcctatggga gtgggcctca gcccgtttct cctggctcag tttactagtg       540\r\n     ccatttgttc agtggttcgt agggctttcc cccactgttt ggctttcagt tatatggatg       600\r\n     atgttgtact gggggccaag tctgtacacc atcttgagtc cctttttacc gctgttacca       660\r\n     attttctttt gtctttgggt atacatttaa                                        690\r\n//\r\n",rel_pat_unc_02_r122.dat
EA028893,US7138514A,"ID   EA028893; SV 1; linear; genomic DNA; PAT; UNC; 182 BP.\r\nXX\r\nAC   EA028893;\r\nXX\r\nDT   07-DEC-2006 (Rel. 90, Created)\r\nDT   07-DEC-2006 (Rel. 90, Last updated, Version 1)\r\nXX\r\nDE   Sequence 4 from patent US 7138514.\r\nXX\r\nKW   .\r\nXX\r\nOS   unidentified\r\nOC   unclassified sequences.\r\nXX\r\nRN   [1]\r\nRP   1-182\r\nRA   Coleman P.F., Mushahwar I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/4, 21-NOV-2006.\r\nRL   Abbott Laboratories;\r\nRL   Abbott Park, IL;\r\nRL   US;.\r\nXX\r\nDR   MD5; ed3fb8082196aff420cd377270c7c0d0.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..182\r\nFT                   /organism=""unidentified""\r\nFT                   /mol_type=""genomic DNA""\r\nFT                   /db_xref=""taxon:32644""\r\nXX\r\nSQ   Sequence 182 BP; 43 A; 57 C; 34 G; 48 T; 0 other;\r\n     tatcaaggta tgttgcccgt ttgtcctcta attccaggat cttcaaccac cagcacggga        60\r\n     ccatgcagac ctgcacgact cctgctcaag gaacctctat gtatccctcc tgttgctgta       120\r\n     caaaaccttc ggatggaaac tgcacctgta ttcccatccc atcatcctgg gctttcggaa       180\r\n     aa                                                                      182\r\n//\r\n",rel_pat_unc_02_r122.dat
EA028892,US7138514A,"ID   EA028892; SV 1; linear; genomic DNA; PAT; UNC; 681 BP.\r\nXX\r\nAC   EA028892;\r\nXX\r\nDT   07-DEC-2006 (Rel. 90, Created)\r\nDT   07-DEC-2006 (Rel. 90, Last updated, Version 1)\r\nXX\r\nDE   Sequence 3 from patent US 7138514.\r\nXX\r\nKW   .\r\nXX\r\nOS   unidentified\r\nOC   unclassified sequences.\r\nXX\r\nRN   [1]\r\nRP   1-681\r\nRA   Coleman P.F., Mushahwar I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/3, 21-NOV-2006.\r\nRL   Abbott Laboratories;\r\nRL   Abbott Park, IL;\r\nRL   US;.\r\nXX\r\nDR   MD5; 7792a057512a3a52e486b023f178bdc6.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..681\r\nFT                   /organism=""unidentified""\r\nFT                   /mol_type=""genomic DNA""\r\nFT                   /db_xref=""taxon:32644""\r\nXX\r\nSQ   Sequence 681 BP; 131 A; 187 C; 144 G; 219 T; 0 other;\r\n     atggagaaca tcacatcagg attcctagga cccctgctcg tgttacaggc ggggtttttc        60\r\n     tggttgacaa gaatcctcac aataccgcag agtctagact cgtggtggac ttctctcaat       120\r\n     tttctagggg gaactaccgt gtgtcttggc caaaattcgc agtccccaac ctccaatcac       180\r\n     tcaccaacct cctgtcctcc aacttgtcct ggttatcgct ggatgtgtct gcggcgtttt       240\r\n     atcatcttcc tcttcatcct gctgctatgc ctcatcttct tgttggttct tctggactat       300\r\n     caaggtatgt tgcccgtttg tcctctaatt ccaggatcat caaccaccag cacgggaccc       360\r\n     tgcagaacct gcacgactcc tgctcaagga acctctatgt atccctcctg ttgctgtaca       420\r\n     aaaccttcgg atggaaactg cacctgtatt cccatcccat catcctgggc tttcggaaaa       480\r\n     ttcctatggg agtgggcctc agcccgtttc tcttggctca gtttactagt gccatttgtt       540\r\n     cagtggttcg tagggctttc ccccactgtt tggctttcag ttatatggat gatgtggtat       600\r\n     tgggggccaa gtctgtacag catcttgagt ccctttttac cgctgttacc aattttcttt       660\r\n     tgtctttggg tatacattta a                                                 681\r\n//\r\n",rel_pat_unc_02_r122.dat
EA028891,US7138514A,"ID   EA028891; SV 1; linear; genomic DNA; PAT; UNC; 1181 BP.\r\nXX\r\nAC   EA028891;\r\nXX\r\nDT   07-DEC-2006 (Rel. 90, Created)\r\nDT   07-DEC-2006 (Rel. 90, Last updated, Version 1)\r\nXX\r\nDE   Sequence 1 from patent US 7138514.\r\nXX\r\nKW   .\r\nXX\r\nOS   unidentified\r\nOC   unclassified sequences.\r\nXX\r\nRN   [1]\r\nRP   1-1181\r\nRA   Coleman P.F., Mushahwar I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/1, 21-NOV-2006.\r\nRL   Abbott Laboratories;\r\nRL   Abbott Park, IL;\r\nRL   US;.\r\nXX\r\nDR   MD5; 03e46608079ed4387ae4ff4f6332bf29.\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFH\r\nFT   source          1..1181\r\nFT                   /organism=""unidentified""\r\nFT                   /mol_type=""genomic DNA""\r\nFT                   /db_xref=""taxon:32644""\r\nXX\r\nSQ   Sequence 1181 BP; 256 A; 351 C; 252 G; 322 T; 0 other;\r\n     atggggcaga atctttccac cagcaatcct ctgggattct ttcccgacca ccagttggat        60\r\n     ccagccttca gagcaaacac caacaatcca gattgggact tcaatcccaa caaggacacc       120\r\n     tggccagacg ccaacaaggt aggagctgga gcattcggac tggggttcac cccaccgcac       180\r\n     ggaggccttt tggggtggag ccctcaggct cagggcataa cacaaacctt gccagcaaat       240\r\n     ccgcctcctg cttccaccaa tcgccagtca ggaaggcagc ctaccccgct gtctccacct       300\r\n     ttgagaaaca ctcatcctca agccatgcag tggaactcca caactttcca ccaaactctg       360\r\n     caagatccca gagtgagagg tctgtatttc cctgctggtg gctccagttc aggaacagta       420\r\n     aaccctgttc cgactactgt ctctcccata tcgtcaatct tctcgaggat tggggaccct       480\r\n     gcgcggaaca tggagaacat cacatcagga ttcctaggac ccctgctcgt gttacaggcg       540\r\n     gggtttttct tgttgacaag aatcctcaca ataccgcaga gtctagactc gtggtggact       600\r\n     tctctcaatt ttctaggggg aactaccgtg tgtcttggcc aaaattcgca gtccccaacc       660\r\n     tccaatcact caccaacctc ctgtcctcca acttgtcctg gttatcgctg gatgtgtctg       720\r\n     cggcgtttta tcatcttcct cttcatcctg ctgctatgcc tcatcttctt gttggttctt       780\r\n     ctggactatc aaggtatgtt gcccgtttgt cctctaattc caggatcttc aaccaccagc       840\r\n     acgggaccat gcagagcctg cacgactcct gctcaaggaa cctctatgta tccctcctgt       900\r\n     tgctgtacaa aaccttcgga tggaaactgc acctgtattc ccatcccatc atcctgggct       960\r\n     ttcggaaaat tcctatggga gtgggcctca gcccgtttct cctggctcag tttactagtg      1020\r\n     ccatttgttc agtggttcgt agggctttcc cccactgttt ggctttcagt tatatggatg      1080\r\n     atgttgtact gggggccaag tctgtacacc atcttgagtc cctttttacc gctgttacca      1140\r\n     attttctttt gtctttgggt atacatttaa accctaataa a                          1181\r\n//\r\n",rel_pat_unc_02_r122.dat
ABL55841,US7138514A,"ID   ABL55841       STANDARD;       PRT;   229 AA.\r\nXX\r\nAC   ABL55841;\r\nXX\r\nSV   ABL55841.1 \r\nXX\r\nDT   06-DEC-2006\r\nXX\r\nDE   Sequence 8 from patent US 7138514.\r\nXX\r\nOS   Unknown\r\nXX\r\nRN   [1]\r\nRP   [1-229]\r\nRA   Coleman,P.F. and Mushahwar,I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/8 21-NOV-2006;\r\nRL   Abbott Laboratories; Abbott Park, IL;\r\nRL   US;\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFT   source          1..229\r\nXX\r\nSQ   SEQUENCE   229 AA;  173A4585 CRC32;\r\n     ARNMENITSG FLGPLLVLQA GFFLLTRILT IPQSLDSWWT SLNFLGGTTV CLGQNSQSPT        60\r\n     SNHSPTSCPP TCPGYRWMCL RRFIIFLFIL LLCLIFLLVL LDYQGMLPVC PLIPGSSTTS       120\r\n     TGPCRXCTTP AQGTSMYPSC CCTKPSDGNC TCIPIPSSWA FGKFLWEWAS ARFSWLSLLV       180\r\n     PFVQWFVGLS PTVWLSVIWM MXYWGPSLYX ILSPFLPLLP IFFCLWVYI                   229\r\n//\r\n",uspto_prt.dat
ABL55840,US7138514A,"ID   ABL55840       STANDARD;       PRT;    61 AA.\r\nXX\r\nAC   ABL55840;\r\nXX\r\nSV   ABL55840.1 \r\nXX\r\nDT   06-DEC-2006\r\nXX\r\nDE   Sequence 5 from patent US 7138514.\r\nXX\r\nOS   Unknown\r\nXX\r\nRN   [1]\r\nRP   [1-61]\r\nRA   Coleman,P.F. and Mushahwar,I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/5 21-NOV-2006;\r\nRL   Abbott Laboratories; Abbott Park, IL;\r\nRL   US;\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFT   source          1..61\r\nXX\r\nSQ   SEQUENCE    61 AA;  3E58125C CRC32;\r\n     YQGMLPVCPL IPGSSTTSTG PCRACTTPAQ GTSMYPSCCC TKPSDGNCTC IPIPSSWAFG        60\r\n     K                                                                        61\r\n//\r\n",uspto_prt.dat
ABL55839,US7138514A,"ID   ABL55839       STANDARD;       PRT;   389 AA.\r\nXX\r\nAC   ABL55839;\r\nXX\r\nSV   ABL55839.1 \r\nXX\r\nDT   06-DEC-2006\r\nXX\r\nDE   Sequence 2 from patent US 7138514.\r\nXX\r\nOS   Unknown\r\nXX\r\nRN   [1]\r\nRP   [1-389]\r\nRA   Coleman,P.F. and Mushahwar,I.K.;\r\nRT   ""Hepatitis B virus surface antigen mutant and methods of detection\r\nRT   thereof"";\r\nRL   Patent number US7138514-A/2 21-NOV-2006;\r\nRL   Abbott Laboratories; Abbott Park, IL;\r\nRL   US;\r\nXX\r\nFH   Key             Location/Qualifiers\r\nFT   source          1..389\r\nXX\r\nSQ   SEQUENCE   389 AA;  548E75AE CRC32;\r\n     MGQNLSTSNP LGFFPDHQLD PAFRANTNNP DWDFNPNKDT WPDANKVGAG AFGLGFTPPH        60\r\n     GGLLGWSPQA QGITQTLPAN PPPASTNRQS GRQPTPLSPP LRNTHPQAMQ WNSTTFHQTL       120\r\n     QDPRVRGLYF PAGGSSSGTV NPVPTTVSPI SSIFSRIGDP ARNMENITSG FLGPLLVLQA       180\r\n     GFFLLTRILT IPQSLDSWWT SLNFLGGTTV CLGQNSQSPT SNHSPTSCPP TCPGYRWMCL       240\r\n     RRFIIFLFIL LLCLIFLLVL LDYQGMLPVC PLIPGSSTTS TGPCRACTTP AQGTSMYPSC       300\r\n     CCTKPSDGNC TCIPIPSSWA FGKFLWEWAS ARFSWLSLLV PFVQWFVGLS PTVWLSVIWM       360\r\n     MLYWGPSLYT ILSPFLPLLP IFFCLWVYI                                         389\r\n//\r\n",uspto_prt.dat
BD004377,JP03074534T,"ID BD004377; SV 1; linear; unassigned DNA; PAT; FUN; 765 BP. XX AC BD004377; XX DT 08-FEB-2002 (Rel. 70, Created) DT 08-FEB-2002 (Rel. 70, Last updated, Version 1) XX DE Process for producing optically active pyridine ethanol derivative. XX KW JP 03074534-T/1. XX OS Candida maris OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Pichiaceae; Ogataea; Ogataea/Candida clade. XX RN [1] RP 1-765 RA Kawano S., Horikawa M., Yasohara Y., Hasegawa J.; RT ""Process for producing optically active pyridine ethanol derivative""; RL Patent number JP03074534-T/1, 19-JAN-2001. RL KANEKA CORP,SHIGERU KAWANO,MIHO HORIKAWA,YOSHIHIKO YASOHARA, UNZO HASEGAWA. XX DR MD5; 2218146abcca965a6b38e58d5384def8. XX CC OS Candida maris CC PN JP 03074534-T/1 CC PD 19-JAN-2001 CC PF 28-JUN-2000 JP 2000004237 CC PR 21-JUL-1999 JP 99P 206503 CC PI SHIGERU KAWANO,MIHO HORIKAWA,YOSHIHIKO YASOHARA,JUNZO HASEGAWA CC PC C12P17/18,C12N9/02,C12P41/00,C12N15/53,C12N15/63,C12N1/21// CC PC (C12N9/02,C12R1:72),(C12N9/02,C12R1:11),(C12N15/53,C12R1:72), CC PC (C12N1/21,C12R1:19) CC CC CC FH Key Location/Qualifiers CC FT source 1..765 CC FT /organism=""Candida maris"" XX FH Key Location/Qualifiers FH FT source 1..765 FT /organism=""Candida maris"" FT /mol_type=""unassigned DNA"" FT /db_xref=""taxon:50260"" XX SQ Sequence 765 BP; 208 A; 173 C; 177 G; 207 T; 0 other; atgtcctaca attttgccaa caaagttctt attgtgaccg gaggtctgtc cggtattgga 60 cttgcagttg caaagaagtt tcttcaactc ggggccaaag tgacaatttc tgatatttct 120 gccactgaaa agtacaacac ggttgtaggt gagttcaaaa ccgagggcat tgatgtcaag 180 aatgttcagt atattcaggc cgatgcaagc aaagaggccg acaacgagaa gctcatctcc 240 gagacactgt ctgctttcgg tgatctcgac tacgtgtgcg caaatgctgg aattgccact 300 ttcacacaga ctacagatat ctcctacgac gtctggagga aggtaaccag cattaatctt 360 gacggtgttt tcatgcttga taaactagct gcacaatact ttttgagcaa gaacaagcca 420 ggtgctattg tcaacatggg ttccattcac tcgtatgtgg ccgctcctgg actttctcac 480 tacggtgcgg ccaaaggagg tctgaagcta ctgactcaga ccatggccct tgagtatgcc 540 gcaaaaggta taagagttaa ctcggtcaat cctggttaca tcaagacacc attgcttgat 600 atttgcccta aagaacacat ggattacctt atcactcagc atccaattgg acgtctcgga 660 aagcctgaag agattgcaag tgctgttgca tttctgtgct ctgacgaggc tacatttatc 720 aacggaatct ccttgttggt agacggtggt tataccgcaa gataa 765 // ",rel_pat_fun_01_r122.dat
